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INTRODUCTION  
 Sexually transmitted disease (STD) refers to a variety of clinical 
syndromes caused by organisms that can be acquired or transmitted 
sexually 15.  Even though STI is a broader entity than STD, the term 
STD and STI are now used synonymously.  
         STDs rank one among the five leading health problems in the 
developing nations (WHO).Women are more susceptible than men for 
acquiring STI from infected partners due to anatomical, physiological, 
immunological, hormonal and social factors. Also, social stigma in 
health care seeking behaviour, specimen collection method, diagnostic 
problems, management difficulties and adverse outcomes further 
complicates the magnitude of the problem in women .37 
          STDs in women are classified into Ulcerative and Non-
ulcerative diseases and vaginal discharge is the commonest 
presentation of Non-ulcerative disease. The problem of vaginal 
discharge is the most frequently narrated complaint of woman in the 
reproductive age group 29. The prevalence of vaginal discharge in India 
was found to be 30% in general population 57 and 50% among 
commercial sex workers74. 
Vaginal discharge can be either physiological or pathological. A 
pathological discharge may be ignored by some females as normal 
discharge, whereas normal physiological discharge may be considered 
as abnormal by some meticulous women.64  
          Infectious causes of abnormal vaginal discharge can be of 
bacterial, viral, fungal or parasitic etiology and successful management 
of vaginal discharge depends on the diagnostic approach. The 
traditional method of diagnosis is through laboratory tests but most of 
the times, this is not possible due to unavailability and expensive 
nature of the tests73. In such situations, a presumptive diagnosis is 
made and syndromic management is given, which is often inaccurate. 
As a result, the patient may remain infective and continue transmitting 
the disease to their contacts. 
           Complications of vaginal discharge syndrome includes adverse 
pregnancy outcomes, pelvic inflammatory disease, infertility, 
malignancy, easy transmission of HIV and others.(37,63) The 
complications and long-term consequences of untreated  STDs not only  
affect the productive population of the society but also the newborn 
babies, who suffer from STDs acquired from infected mothers and face 
potentially serious consequences. 
          In contrast to the previous assumption of only Ulcerative STDs 
favours the acquisition of HIV, Non-ulcerative STDs also increases 
HIV acquisition by two fold41 thus increasing the HIV burden of the 
Nation in addition to the increased morbidity and mortality. The 
prevalence and incidence of STIs can be used as a proxy marker for 
assessing the behavioural changes in the target population and thus 
indirectly measures HIV incidence. 
          Since Cervico-vaginal discharge is a common problem which is 
manageable, the list of adverse outcomes that occur due to vaginal 
discharge syndrome are preventable and female sex workers form one 
of the core group for the spread of STIs to the general population, this 
study on Cervico-vaginal discharge in high risk women is important 
for the patient  management  as well as for preventing transmission of 
the infection to the general population through their clients who acts as 
bridge group connecting the High risk group and the general 
population. Therefore this study was done to analyse the various 
aspects of Cervico-vaginal discharge with the aim of establishing 
etiological diagnosis and achieving complete cure. 
 
 
AIMS & OBJECTIVES 
1. To study the prevalence of  various etiological agents of 
Cervico-vaginal discharge  
2.  Comparison of different methods of diagnosis for various 
etiologies of Cervico-vaginal discharge. 
3. Identification of co-infections 
4.   Determination of antimicrobial susceptibility pattern of the 
bacterial and fungal isolates 
5.    Evaluation and comparison of syndromic , clinical and 
etiological diagnosis. 
 
 
 
 
 
 
 
REVIEW OF LITERATURE 
History: 
“Venereal diseases are like fine arts –it is pointless to ask who 
invented them”- Voltaire (French philosopher).11 
The history of sexually transmitted disease in India has been 
dated to mid sixteenth century in an ancient book called 
Bhavaprakasa.It has been mentioned in Bible that syphilis and 
gonorrhea were ancient as well as contemporary burdens. Gonorrhea 
and syphilis were called "the great imitator" by the eminent physician 
William Osler. The late nineteenth and early twentieth centuries saw 
major breakthroughs in the understanding of syphilis and gonorrhoea 
when, the causative agent of gonorrhoea, Neisseria gonorrhoeae was 
discovered by Albert Neisser and  the causative agent of syphilis, 
Treponema pallidum was identified by  Fritz Richard Schaudinn  and 
Paul Erich Hoffmann. 
The sexually transmitted diseases were major problems during 
World Wars I and II. The caption of a  poster from world war II read 
"V.D. Worst of the Three," suggesting that venereal disease could 
destroy American troops faster than either of America's two declared 
enemies (Germany and Japan). 
Prostitution as a profession has been there since long time in 
India. The devadasi (handmaiden of god) system also called as sacred 
prostitution has been there since 300 AD. In the modern era, many 
women enter this profession due to life circumstances and its 
consequences.1.Women having no support either widowed or abused 
by their husbands and in-laws, entering this profession as a means to 
support themselves 2.Women choosing this profession for fulfilling 
their sexual urge or were curious18.Female sex worker (FSW) by 
definition is a woman who provides sexual service for immediate cash 
or for in kind returns22. These sex workers and their clients form the 
“core group” and “bridge group” for transmission of STDs and HIV to 
the general population.  
Sexually transmitted infection (STI) rates are occurring in higher 
percentage among population subgroups such as commercial sex 
workers, since they tend to have high rates of partner change and 
unprotected sex. Therefore, maximum preference is given to this group 
in targeted intervention for prevention of HIV/AIDS.67The entry of 
deadly HIV into India in 1986 also contributed to the increased 
awareness and fear on STD and its prevention.  
 
 Anatomy of vagina65: 
The female external genitalia comprises of vulva, urethra, vagina 
and uterus.Vagina is a fibro muscular tube extending from vestibule to 
cervix. Length of vagina is about 9 cm anteriorly and 11.5 cm 
posteriorly. It forms a cuff around the lower two thirds of the cervix 
and thus forming an anterior, posterior and two lateral fornices. 
Functions of vagina are, it plays role in sexual activity, child birth and 
acts as a passage for the uterine secretions to be passed out.  
Vaginal discharge: 
Vaginal dischargeconstitute a major problem for many women 
causing discomfort and anxiety affecting their quality of life. Normal 
vaginal discharge has the following characteristics4.It is whitish,non- 
offensive, floccular in consistency and the pH varies for different age 
groups. 
Age 
group 
New 
born to 
Neonate 
Neonate 
to 
puberty 
Puberty to 
Menopause 
Pregnancy Post 
menopause 
pH 4 7 3.8-4.5 4-4.2 6.0-7.5 
 The constituents of normal vaginal discharge are sloughed 
columnar epithelial cells of cervix and squamous epithelial cells of 
vagina, serous transudate of vagina and mucous secretion of cervix, 
organic compounds like carbohydrates, fatty acids, proteins and normal 
flora which includes Lactobacillus crispatus, L.jensenii, L.gasseri and 
L.iners. The uterus and fallopian tube contribute very less to the 
vaginal discharge. 
         Vaginal discharge should be considered abnormal when any one 
of the following feature is present.32 
1. Increased amount of discharge not associated with menstruation 
2. Abnormal odour 
3. Yellow coloured discharge 
        The causes of vaginal discharge can be physiological or 
pathological.4 
I. Physiological causes 
     1. Age dependent 
          Neonate, Pre puberty and Child bearing 
    2. Excessive secretion 
          Sexual arousal and Pregnancy 
 II. Pathological: 
    1. Infective:  
           a. Gardnerella vaginalis and list of Anaerobes 
           b. Trichomonas vaginalis 
           c. Candida species 
           d. Neisseria gonorrhoeae 
           e. Chlamydia trachomatis D-K 
  f. Aerobic bacteria like Staphlococcus aureus, Streptococcus 
species, Escherichia coli and others 
     2. Non-infective: 
           a. Chemical irritants: 
Antiseptics, Detergent spermicide, Douches, Deodrants           
          b. Gynaecological conditions: 
Endo cervical polyp, Fistula, Radiation effects, Post    
operative and tumors  
          c. Foreign bodies: 
              Intrauterine contraceptive device (IUCD) 
          d. Medication and nutrition. 
 
 Epidemiology70: 
The estimated global occurrence of curable STI among adults 
was about 400 million in 1995. Out of this total disease burden, south 
and south-east Asia holds about 150 million, for which India’s 
contribution is about 50 million. In 1990, WHO estimated that over 
250 million new cases of STIs had occurred in that year globally. In 
1995, the number of new cases of STIs had shot up to 333 million and 
in 1999, it became 340 million. 
The STI trend in countries of Southeast Asian region shows 
wide differences. In Bangladesh, about 2.5 million persons are infected 
with STIs. In Bhutan, STIs are a major burden with gonorrhoea being 
the most common STI. In Myanmar the prevalence of major STIs per 
100 000 population for the year 2000 are: syphilis -12.6; gonorrhoea - 
4.2; non-gonococcal urethritis - 5.4; and chancroid -1.8. Genital herpes 
is the commonest reported STI and bacterial STIs are showing a 
decline in Srilanka.STIs are of low prevalence in Maldives.In Thailand 
the prevalence of major bacterial STI  has decreased since 1989 with a 
slight increase in gonorrhoea cases in 2000. 
 
In India, Tamil Nadu showed the prevalence of gonorrhoea to be 
3.7% and chlamydia to be 3.9%, syphilis 0.3% and  trichomoniasis 
5.1%.A study carried out amongst sex workers  revealed that 75% had 
at least one STI and also multiple infections occurred commonly. The 
prevalence of commonly encountered  STIs include hepatitis B (5.3%), 
trichomoniasis (5.1%), chlamydial infection (3.9%), gonorrhoea 
(3.7%), HIV infection (1.8%), syphilis (0.3%), and 
chancroid(0.1.%).Amongst high-risk groups,syphilis was  the 
commonly found STI in Tamil nadu, while trichomoniasis was the 
commonest STI in Kerala73. 
The data from southeast region shows that wide variations exist 
between regions and within countries in the same region, between 
urban and rural population, and even in similar population groups. 
There is a need to have this information for instituting preventive 
measures and providing good quality STI care to the population. 
According to WHO, effective control of STI needs research activities 
like STI prevalence study, Gonococcal antimicrobial survillence and 
studies on cervicitis syndrome. 
 
 
Vaginal discharge syndrome and HIV: 
Women with bacterial vaginosis has two fold increased risk of 
acquiring HIV infection. Trichomoniasis was associated with 1.7 fold 
41
 and 1.5 fold52 increased risk for acquiring HIV infection.Untreated 
vulvovaginal candidiasis is a possible risk for acquisition of 
HIV72.Gonorrhoea increases the risk of acquisition of HIV by 2-5 fold 
and  Chlamydia trachomatis infection have 3-5 fold increased risk for 
acquiring HIV infection. 
BACTERIAL VAGINOSIS17: 
Introduction: 
Bacterial vaginosis is also called as Anaerobic vaginitis /Vaginal 
bacteriosis.It is called vaginosis due to absence of inflammation. 
Bacterial vaginosis is described as a polymicrobial syndrome 
characterised by replacement of normal vaginal lactobacilli by 
anaerobic bacteria and mycoplasmas. Gardner and Dukes were the first 
to describe this syndrome as Hemophilus vaginalis vaginitis in 
1955.Bacterial vaginosis was the most common infection among 
women visiting reproductive health clinic. In rural population of south 
India, the prevalence was found to be 17 % among sexually active age 
group. 
Etiology(1,17,55) 
List of organisms responsible for this syndrome are Gardnerella 
vaginalis, Mobiluncus species, Prevotella, Mycoplasma hominis, 
Bacteroides ureolyticus, Porphyromonas, Peptostreptococcus, 
Corynebacterium, Streptococcus viridians, Coagulase negative 
staphylococcus, Enterococcus faecalis, Clostridium species and 
Fusobacterium. 
Pathogenesis: 
Normal vaginal flora is replaced by profuse mixed flora and 
there is also a quantitative increase in bacteria to 100-1000 times the 
normal. Production of amines by decarboxylation of amino acids and 
fatty acids by the mixed flora results in rise of vaginal pH and 
promotes growth of anaerobic organisms. 
Hypothesis in pathogenesis are  
• Gvh toxin is a haemolytic toxin produced by Gardnerella 
vaginalis and women who manifest bacterial vaginosis are those 
who lack an adequate IgA response against this toxin. 
• Anaerobic organisms produce hydrolytic enzymes like sialidase 
and dipeptidase which lyse the mucin and helps in adherence of  
bacteria to the vagina. 
Clinical features: 
Homogenous, white discharge that smoothly coats the vaginal 
walls, with characteristic amine odour, pruritis, dysparenuia and lower 
abdominal pain. 
Diagnosis: 
Amsel’s criteria is used to clinically evaluate the discharge 
based on simple tests. Nugent scoring of gram stained smear based on 
the number of certain bacterial morphotypes. Hays/Ison system is 
based on gram stain observation of ratio of  different morphotypes 
rather than the exact number of bacteria present. Schimdt’s scoring 
system is done on wet mount of vaginal smears,similar to nugent 
scoring system but does not recognise Mobiluncus species. Anaerobic 
culture methods are needed since most organisms responsible for 
bacterial vaginosis are obligate anaerobes. Gas liquid 
chromatography measures the ratio of succinate to lactate peaks. A 
value of greater than 0.4 is used as a predictor for bacterial vaginosis. 
Sialidase activity and DNA probes for Gardnerella vaginalis are also 
available. 
 
 
Complications: 
Miscarriage, pre term delivery, low birth weight baby, premature 
rupture of membranes, chrioamnionitis, postpartum endometritis, 
vaginal cuff cellulitis, pelvic inflammatory disease. 
Treatment:  
Metronidazole / Tinidazole 2g single dose should be given orally 
or Metronidazole 400 mg should be given twice daily for 7 days. 
TRICHOMONIASIS63:  
Introduction: 
  Trichomoniasis is a protozoal parasitic sexually transmitted 
disease. Donne first described Trichomonas vaginalis in  the vaginal 
discharge in 1936. Annual worldwide incidence of Trichomoniasis is 
more than 170 million and this infection accounts for almost half of all 
curable sexually transmitted infections(WHO).The prevalence of 
Trichomoniasis was found to be 0.4- 27.4 % in women. 
Etiology: 
This is an obligate parasite that lacks the ability to synthesise the 
macromolecules de novo. It also lacks mitochondria and posses 
hydrogenosomes to accomplish fermentative carbohydrate metabolism 
with hydrogen as electron acceptor. 
Pathogenesis: 
The three mechanisms involved in pathogenesis are  
1. Contact dependent: Trichomonas vaginalis attaches to the 
epithelial cells by means of adhesion proteins AP 65, AP 33, 
AP 23. The laminin protein of the host can act as target for 
adhesion of the parasite.The haemolytic activity of the parasite  
also has a role in virulence. 
2. Contact independent: The parasitic product called cell 
detaching  factors (CDF) have trypsin like activity, which is 
supposed to play role in pathogenesis. 
3. Immune response: Trichomonas vaginalis evades the immune 
system by complement mediated destruction, molecular 
mimicry and by its ability to coat itself with host proteins. 
Clinical features: 
About 50% are asymptomatic and others can present with 
symptoms like vaginal discharge which is frothy, foul smelling, green 
or yellow in colour, pruritis, dysuria, dysparenuia and lower abdominal 
pain 
 
Diagnosis: 
Clinical evaluation: Characteristic frothy discharge will be 
present in only 10% female and strawberry cervix will be present in 
only 2% female. The typical features are present only in fewer 
percentage of individuals and if clinical diagnosis was made, about 
88% of infected women will not be diagnosed and 29% of uninfected 
female will be diagnosed as having Trichomoniasis. 
Wet mount: The presence of Trichomonas vaginalis was 
determined by the morphology (10X7 µm size, pear shaped) and 
characteristic twitching motility. It needs a minimal concentration of 
104 organisms /ml of vaginal secretion to be picked up by this method. 
Since the parasite lose its motility on cooling at room temperature and 
can survive in saline only for 20 min49, the microscopy should be done 
immediately. Sensitivity depends on the expertise of the examiner and 
is about 55%. 
Staining methods: Various stains that can be used are Giemsa 
stain, Acridine orange, Leishman stain, Periodic acid –Schiff and 
Fontana stain. 
Culture method: Culture is the gold standard for diagnosis of   
Trichomoniasis. It can pick up positivity if 300-500 organisms/ml were 
present in the specimen. The positivity of culture is as twice as wet 
mount. It needs 2-7 days to show positivity. The media widely 
available for culture are Diamond’s/ modified diamond’s medium, 
CPLM (Cysteine peptone liver infusion  maltose) /modified CPLM 
medium, Feinberg Whittington medium, Lash medium, Kupferberg 
medium, Agar culture and In Pouch TV culture. 
Cell culture method: This method was reported to be superior 
to broth culture and microscopy since it can detect parasite even as low 
as 3 organisms/ml present in the vaginal fluid. It is not used routinely 
due to cost and time factors. 
Rapid tests: Immunochromatographic based tests and 
Polymerase chain reaction (PCR) based methods are also available. 
Complications: 
Pre term labour, pre mature rupture of membranes, low birth 
weight infant, infertility, malignancy like Cervical cancer (Seema sood 
et al),risk of developing prostate cancer that was diagnosed at an 
advanced stage (Jennifer et al 33),risk factor for acquisition of  HIV, 
other STI s and vice versa.  
Treatment:  
Metronidazole / Tinidazole 2g single dose should be given orally or 
Metronidazole 500 mg orally should be given twice daily for 7 days. 
Resistance: Trichomoniasis is said to be clinically resistant if there is 
failure to cure the infection after atleast 2 consecutive courses of 
metronidazole.  Prevalence of metronidazole resistance was estimated 
to be 2.5-5% . 
VULVOVAGINAL CANDIDIASIS4 
Introduction: 
Vulvovaginal candidiasis is a fungal disease which is not only 
sexually transmitted but can be acquired due to variety of other 
reasons. Lagenbeck first demonstrated the fungus in thrush in 
1839.Candidiasis accounts for 15-30% of etiological agent of vaginal 
discharge. 
Etiology: 
Candidiasis is caused mostly by Candida albicans and the rest 
by non –albicans, among which Candida glabarata is the commonest 
species. 
Pathogenesis:  
The important defense mechanism against candidiasis is the 
normal natural bacterial flora. The organism should adhere to the 
epithelial cells, proliferate and germinate for establishing colonisation 
and symptomatic inflammation. Candida can gain access to the vaginal 
epithelium from adjacent perianal area. Spontaneous phenotypic 
switching occurs and this variant phenotype has the capacity to form 
mycelia, express virulence factors, adhere and invade to cause disease. 
This spontaneous phenotypic switching can convert asymptomatic 
colonization to symptomatic vaginitis.  
Risk factors: 
Pregnancy,uncontrolled diabetes mellitus, corticosteroid therapy, 
tight fitting synthetic underclothing, antimicrobial therapy, oestrogen 
therapy, HIV infection and contraceptives like IUCD, sponge, 
nonoxynol-9 and diaphragm. 
Clinical features: 
Thick curdy white discharge-cottage cheese like in character,  pruritis, 
soreness or irritation, burning/ dysuria and dyspareunia. 
 
Diagnosis: 
KOH mount: Direct examination of the discharge done with 
10% KOH will show yeast cells of size 4-6µm which will be smaller 
than pus cells (7µm). It has a greater significance if pseudohyphal 
forms are seen. Gram stain: Gram positive yeast cells with budding 
and pseudohyphae will be seen. If direct microscopy is positive, 
Culture is usually not needed to establish diagnosis. Culture: Culture 
should be done in microscopy negative clinically suspicious cases and 
also in resistant and recurrent cases. Rapid tests: Latex agglutination 
test are available with reported sensitivity and specificity of 81% and 
98%.  
Complications: 
Recurrence and psychological stress 
Treatment: 
Fluconazole 150 mg single dose should be given orally. 
GONOCOCCAL CERVICITIS71: 
Introduction: 
Gonorrhoea is derived from two words- gono meaning ‘seed’  
and rhoea meaning ‘flow’ . Albert Neisser identified the organism 
Neisseria gonorrhoeae in 1879. 
Etiology: 
Neisseria gonorrhoeae.  
Pathogenesis: 
N.gonorrhoeae affects the columnar epithelium. Infection is 
established in three steps.1.Adherence 2.Invasion and  3.Tissue 
damage. 
Clinical features: 
About 50% are asymptomatic or can have mucopurulent 
discharge, dysuria, menorrhagia and other menstrual irregularities. 
Diagnosis: 
Microscopy: Specificity is 40-60% in endocervical secretion 
and is negative in asymptomatic individuals while the specificity is 95-
97% in male urethral samples. Culture: Various culture media used 
are Modified Thayer Martin medium, Chacko Nayar medium , Martin 
Lewis medium and New York City medium. Polymerase chain 
reaction and Ligase chain reaction and serological methods like 
Latex agglutination, anti surface pili assays and ELISA are available. 
  
 
Complications: 
Acute pelvic inflammatory disease, infertility, ectopic 
pregnancy, neonatal complications like opthalmia neonatorum, 
Gonococcal arthritis, meningitis, endocarditis and disseminated 
gonococcal infection, the prevalence of which is about 0.1 to 0.3 of the 
total infection. 
Treatment: 
Cefixime 400mg single dose or ciprofloxacin 500 mg single 
dose should be given orally or ceftriaxone 125mg single dose should 
be given intramuscularly. 
CHLAMYDIAL CERVICITIS66: 
Introduction: 
Chlamydia is derived from word ‘cloak’ . Neisser (who also 
discovered N.gonorrheaee) along with Ludwig Halberstaedter and 
Stanislaus von Prowazek discovered Chlamydia. Ludwig Waelsch, 
famous German microbiologist was the first to describe Chlamydia. It 
is the most commonly reported STI and the commonest notifiable 
infectious disease in developed countries.The prevalence was 36-41% 
in northern states of India. 
 
Etiology:  
Chlamydia genus involves 4 species. Chlamydia trachomatis is 
one among them and is divided into many serovars. Serovars D-K are 
associated with chlamydial cervicitis. 
Pathogenesis:  
Chlamydia is an obligate intracellular pathogen and exhibits a 
biphasic cycle altering between two morphologically distinct forms, 
elementary body (infectious) and reticulate body. 
Clinical features: 
87% of women are asymptomatic and others can have 
mucopurulent discharge or hypertropic ectopy. 
Diagnosis: 
Isolation in cell culture: McCoy, HeLa are the cell lines that 
support the growth of Chlamydia. Cell culture is highly specific 
(100%) and this method should be adopted to establish the diagnosis in 
medico legal cases. Antigen detection: Direct fluorescent antibody 
(DFA) test, Enzyme linked immune sorbent assay (ELISA),Nucleic 
acid hybridisation technique and Polymerase chain reaction can be 
used for antigen detection. Serological methods like Microimmuno 
fluorescence and ELISA are also available 
Complications: 
Pelvic inflammatory diseases, tubal occlusion leading to ectopic 
pregnancy and infertility, Fitz-hugh-curtis syndrome, spontaneous 
abortion, low birth weight baby and neonatal complications like 
conjunctivitis and pneumonia. 
Treatment  
Doxycycline 100 mg orally should be given twice daily for 7 
days or Azithromycin 1g single dose should be given orally. 
 
 
 
 
 
 
 
 
 
MATERIALS AND METHODS 
TYPE OF STUDY: Cross sectional comparative study. 
PLACE OF STUDY: 
This study has been conducted in the Department of 
Microbiology, Stanley Medical College in association with Department 
of Sexually Transmitted Diseases, Government Stanley hospital, 
Chennai. 
PERIOD OF STUDY: May 2011 to April 2012. 
STUDY POPULATION: 
Female outpatients attending Sexually Transmitted Infection 
clinic, were enrolled into the study. 
 
INCLUSION CRITERIA 
1. Women who presented with C/O vaginal discharge 
(symptomatic/subjective vaginal discharge).  
2. Women who presented with complaints other than vaginal 
discharge, but had discharge on examination (asymptomatic 
/objective vaginal discharge). 
3.  Sexually active age group (15-49 years) 
4. High risk group - Female sex workers 
                               Housewife with multiple partners 
                              Female with high risk partner 
                              Female with other venereal diseases 
                              Female with H/O diabetes and steroid intake 
       5. Low risk group - Absence of the above mentioned risk factors 
EXCLUSION CRITERIA 
1. Extremes of age. 
2. Women in Menstruation or with Genital prolapse  
3. Females with H/O treatment for discharge syndrome within 2 
weeks prior to the visit. 
ETHICAL CONSIDERATION 
Ethical and research clearance was obtained from the Ethical 
Committee, Stanley Medical College. Informed consent was obtained 
from the patients before enrolment into the study.  
 
 
 
STATISTICAL ANALYSIS 
Statistical analysis was done using IBM-SPSS Statistics -20 
statistical package. Variables were analysed using student‘t’  test, Chi 
square test and Z test of proportions wherever necessary. The P value 
less than 0.05 (P<0.05) were treated as significant in two tail test.  
SPECIMEN COLLECTION: 
Consent was obtained from the patient and after wearing sterile 
gloves, four High vaginal swabs, two cervical swabs and 5 ml of blood 
were collected from each patient. 
Speculum examination: Patient was asked to lie in dorsal 
position and draw the heels towards her bottom and then widely 
separate the knees. The speculum was inserted into the vagina and all 
the aspects of vagina and cervix are examined for presence or absence 
of erythema, ulceration, Mucopurulent cervicitis and vesicular lesions 
of vulva or vagina. The nature, colour, amount, consistency and 
location of discharge in the vagina were noticed.  
High vaginal swab55: A sterile cotton swab was inserted into the 
vagina and the material collected from the posterior and lateral 
fornices. 
Cervical swab55: Ectocervix was cleaned using sterile cotton 
swab and using another sterile cotton swab, the sample was collected 
from the endocervical canal. 
Serum: About 5 ml of blood was collected and serum was 
separated by centrifuging at 1500 rpm for 5-10 min at room 
temperature. Serum was then stored in sterile container at -20°C.  
PROCESSING OF SPECIMEN: 
Discharge from speculum was subjected to Saline wet mount, 
KOH mount and Amsel’s criteria 
High vaginal Swab 1: Gram stain for Nugent score, Modified 
Donder’s score,  Giemsa stain for Trichomonas vaginalis 
High vaginal Swab 2: Inoculated into Blood agar and Human 
bilayer tween Blood agar for culture of Aerobic and Anaerobic 
organisms 
High vaginal Swab 3: Inoculated into Modified CPLM 
(Cysteine, Peptone, Liver infusion, Maltose) medium for isolation of  
Trichomonas vaginalis 
High vaginal Swab 4: Inoculated into Sabouraud’s dextrose 
agar for culture of Candida species 
Cervical Swab 1: Gram stain to look for pus cells with or 
without organisms especially intracellular diplococci 
Cervical Swab 2: Inoculated into Modified Thayer martin 
medium for isolation of Neisseria gonorrhoeae  
Serum was subjected to test for HIV, Rapid Plasma Reagin test 
for Syphilis and ELISA for detection of Chlamydia IgM, IgG 
antibodies 
Tzanck smear-Giemsa stain was done to look for multi 
nucleated giant cells of Herpes simplex virus 
Saline wet mount: A drop of vaginal discharge was put in a 
clean grease free slide, mixed with a drop of normal saline and 
examined first under 10X, then under 40X magnification to look for 
normal vaginal epithelial cells, Clue cells, Pus cells and motile 
Trichomonas vaginalis. 
KOH mount: A drop of 10% KOH was added to the discharge 
placed on a clean slide and examined for budding yeast cells and 
pseudohyphae. 
 
 
Amsel criteria50: 
1. Homogenous discharge 
2. PH  4.5 
3. Presence of amine odour which is demonstrated by adding 
10% KOH to the discharge and this occurs due to the 
production of amines like cadaverine, trimethyl amines and 
putrescene. 
4. Presence of clue cells (20%) in the wet mount. Clue cells are 
defined as squamous epithelial cells studded with 
coccobacilli thus obscuring the nucleus and giving a granular 
appearance.  
Presence of 3 out of 4 is significant for diagnosis of bacterial 
vaginosis 
5. Absence of lactobacilli is an additional criteria. 
Vaginal Swab 1: was used for Gram stain and Giemsa stain  
Preparation of smear: Clean grease free slide was taken and 
labelled. Smear was prepared by rolling the swab on the slide in one 
direction. Unidirectional smearing minimizes distortion and breakage 
of polymorphonuclear leukocytes (PMNL) and thereby preserves the  
Wet mount under 40x showing clue cells 
 
 
Wet mount under 40x showing  pear shaped Trichomonas vaginalis 
 
 
  
KOH mount under 40x showing Yeast cells &Pseudohyphae 
 
 
pH measurement for Amsel criteria 
 

 
morphology of the cells and location of microorganisms. The smear 
was air dried and gram stain was performed. 
Nugent scoring of Gram stained smear for Bacterial vaginosis. 9 
ORGANISM 
MORPHOTYPE 
NUMBER/OIL 
IMMERSION FIELD 
SCORE 
 Lactobacillus -
like(parallel sided, gram 
positive rods) 
>30 0 
5-30 1 
1-4 2 
<1 3 
0 4 
Mobiluncus –
like(curved,gram 
negative rods) 
>5 2 
<1-4 1 
0 0 
   Gardnerella 
bacteroides –
like(tiny,gram variable 
coccobacilli and 
pleomorphic rods with 
vacuoles) 
>30 4 
5-30 3 
1-4 2 
<1 1 
0 0 
Total score:-                                           
                0-3     Normal 
                4-6     Intermediate, repeat test later 
                7-10   Bacterial vaginosis 
 
Gram stain under oil immersion showing Normal vaginal epithelial 
cells with Lactobacilli 
 
 
 
Gram stain under oil immersion showing Cluecells with absence of  
Lactobacilli 
 
Gram stain under oil immersion showing Mobiluncus species 
(Curved Gram negative rods) 
 
 
Gram stain vaginal smear showing Gram positive yeast cell with 
pseudohyphae 
 
 
Modified Donder’s grading of Gram stained smear for Aerobic 
vaginosis 25 
Score Lacto 
bacillary 
grade 
No.of 
leucocytes 
Proportion of 
toxic leucocytes 
Background 
flora 
Proportion 
of 
parabasal 
cells 
0 I,II A  10/hpf None or 
sporadic 
Unremarkable/
cytolysis 
None or 
<1% 
1 II B >10/hpf or 
10/epi cell 
50%of 
leucocytes 
Small 
coliforms 
10% 
2 III >10/epi cell >50% 
leucocytes 
Cocci in chains >10% 
 
Total score:- 
<3 - Normal 
3-4-   Slight aerobic vaginosis 
5-6-   Moderate aerobic vaginosis 
6-10- Severe aerobic vaginosis  
 
 
Giemsa stain was done to look for pear shaped Trichomonas 
vaginalis. 
1. The smear was fixed in methanol for 5 min 
2. The slide was stained with Giemsa stain diluted to 1in 10 
with buffered distilled water 
3. The stain was allowed to stand for 30 min 
4. The slide is then washed with distilled water. 
5. The findings were observed under oil immersion. 
Vaginal Swab 2: was inoculated in Blood agar and Human blood  
bilayer tween agar.The blood agar was incubated aerobically and 
Human blood bilayer tween agar was incubated in anaerobic 
atmosphere using McIntosh Fildes jar at 37oC for 48 hrs. 
Aerobic organisms were identified based on the colony 
morphology, Gram stain and biochemical reactions. Antibiotic 
susceptibility test performed by Kirby-bauer disc diffusion method as 
per Central Laboratory Standards Institute(CLSI ) guidelines. 
 Gardnerella vaginalis39 were identified by observing for tiny 
translucent  beta haemolytic colonies which were catalase and oxidase 
negative and Gram stain showing gram negative coccobacilli.  
  
 
 
 
Giemsa stain under oil immersion showing pear shaped 
Trichomonas vaginalis 

 
 
 
 
 
 
 
 
 
 
Gram stain of culture smear showing Gram negative cocobacilli 
(Gardnerella vaginalis) 
 
 
                      Antibiotic sensitivity test for Gardnerella vaginalis 
 
P 
Ba 
SPS 
Va
Met 
Tri 
Identification discs like Metronidazole 50µg, Bacitracin 5 IU and SPS 
(Sodium Polyanethol Sulphonate) disc 100µg prepared by adding 20µl 
of 5% solution of SPS to sterile Whatman No.1 filter paper disc  were 
used43. 
Obligate anaerobes were identified based on colony morphology, 
beta hemolysis, pigment  production,  swarming,  aerotolerance test 
and Gram stain findings. Differential discs used were Vancomycin 
5µg, Colistin10µg and Kanamycin1 mg. 
Identification of anaerobes using differential discs8 
Organism Kanamycin 
1mg 
Vancomycin 
 5µg 
Colistin 
10µg 
Bacteroides 
ureolyticus 
S R S 
Prevotella R R S 
Porphyromonas R S R 
Fusobacterium S R S 
Peptostreptococcus R S R 
Clostridium S S R 
Eubacterium S S R 
 
S (sensitive)   >10 mm   
R (resistant)   <10 mm 
Vaginal Swab 3: was inoculated in Modified CPLM (Cysteine, 
Peptone, Liver infusion, Maltose) medium and incubated in Co2 
atmosphere for 7 days. Wet mount was prepared from the medium 
everyday to look for motile Trichomonas vaginalis. 
Vaginal Swab 4: was inoculated into Sabouraud’s dextrose agar 
and incubated at 25-27oC. 
Colony morphology- Pasty, opaque, cream coloured circular 
colonies grow in 24-48 hours.  
Gram stain –Gram positive budding yeast cells. 
Germ tube test40: 
Few colonies were inoculated into 0.5 ml of human serum and 
incubated at 37ºC for 2 hours. After 2 hours, wet mount was prepared 
and observed under 40 X objective. A germ tube is a short, lateral 
hyphal extension (filament) of the yeast cell without constriction at the 
base. Observation of germ tube suggests the presence of Candida 
albicans. Absence of germ tube indicates that the species belongs to 
non-albicans candida. 
 
 
Modified CPLM medium for Trichomonas vaginalis 
 
 
 
Cultures of various species of Candida in SDA 
 
 
 
Uninoculated 
medium 
Positive culture 
with turbidity 
 Gram stain of Candida culture showing Gram positive yeast cells 
 
 
Germ tube test positivity of Candida albicans 
 
CHROM agar 
The colony was inoculated on CHROM agar medium and 
incubated at 30oC for 48 hrs and species were identified based on the 
colour. 
                  Speciation of Candida by CHROM agar31 
Species Colour 
C.albicans Light green 
C.glabarata Pink to purple 
C.tropicalis Blue with pink halo 
C.parapsilosis Cream to pale pink 
C.krusei Pink 
C.dublinensis Dark green 
 
Corn meal agar7 
The tween incorporated in Corn meal agar medium and the 
subsurface inoculation technique provides a low surface tension to 
allow for the development of pseudohyphal and hyphal forms, 
blastoconidia and chlamydoconidia. Isolated colony from pure culture 
was streaked in cornmeal agar medium as two parallel streak lines ½ 
inch apart at 45 degree angle to the medium. A sterile cover slip was 
placed on the streaked area and incubated at 270C for 48 hrs and 
observed under 10 X and 40 X. 
        Speciation of Candida by cornmeal agar58 
                      Species          Morphology 
C.albicans Terminal and intercalary 
chlamydospores 
C.glabarata No pseudohyphae,only 
blastoconidia 
C.tropicalis Branching pseudohyphae and 
blastoconidia 
C.parapsilosis Curved pseudohyphae and 
blastconidia 
C.krusei Pseudohyphae and blastoconidia 
resembles crossed match stick 
C.dublinensis Terminal and intercalary 
chlamydospores 
 
Carbohydrate assimilation test 7 
Carbohydrate free medium (Yeast nitrogen base agar ) 
containing bromocresol purple was inoculated with suspension of 
yeast corresponding to McFarland No.4 turbidity standard. 
Carbohydrate discs were placed on the inoculated medium and 
incubated at 30oC for 48 hrs. Change in colour of the medium or  
CHROM agar showing various species of Candida 
 
Corn meal agar under 40X showing blastospores and terminal 
chlamydospores of Candida albicans 
 
C.krusei 
C.tropicalis 
C.glabarata 
C.albicans 
C.parapsilosis 
C.tropicalis 
growth around the disc were considered positive for utilisation of 
carbohydrate. 
 
Speciation of Candida by carbohydrate assimilation30 
    Species Xyl Lac Suc Mal Mel Cel Tre 
C.albicans + + + _ + + + 
C.tropicalis + _ + + _ + + 
C.glabarata + _ _ _ _ _ + 
C.parapsilosis + _ + + _ _ + 
C.krusei + _ _ _ _ _ _ 
C.dublinensis + + + _ + + + 
Xyl-xylose,Lac-lactose,Suc-sucrose,Mal-maltose,Mel-melibiose,Cel-
celibiose, Tre-trehalose 
Antifungal susceptibility test: 
Disc diffusion (M44- A2): 
Mueller Hinton agar with 2% glucose, 0.5µg/ml methylene blue 
added to the medium for easy identification of zone size was used. 
Inoculum standardised to 0.5 McFarland standard and after placing the 
discs, plates were incubated at 350C for 24 hrs. For azoles the zones  
 
Carbohydrate assimilation test for Candida (before incubation) 
 
Carbohydrate assimilation test for Candida tropicalis (after 
incubation) 
   
Candida tropicalis –Assimilation positive for Xylose, Sucrose, 
Maltose, Celibiose and Trehalose 
Tre 
Cel 
Mel 
Suc     
Lac 
Xyl 
Mal 
 Suc 

Mal 
    Cel 
Tre 
Lac 
Mel 
    Xyl 
were measured up to colonies of normal size and for Amphotericin B, 
the clear zone with no visible growth was measured  
                   Interpretive zone diameter  
 
Drug 
Sensitive 
(mm) 
Intermediate 
(mm) 
Resistant 
(mm) 
Fluconazole 25µg        19 15-18(SDD)* <14 
Itraconazole 10 µg 23 14-22(SDD) <13 
  Amphotericin B 20µg  15         10-14 <10 
        SDD*-Susceptible dose dependent 
Minimum Inhibitory Concentration by Microbroth dilution          
(M 27 -A3):  
Procedure was done using RPMI-1640 medium (with glutamine 
without bicarbonate ) supplemented with 0.2% glucose and buffered to  
pH of 7.0 with 0.165 mol/L MOPS(3-[N-morpholino] propane sulfonic 
acid). Standard inoculum of 0.5 McFarland was used and incubated at 
350C. Interpretation was done at 24 hrs using a reading mirror and the 
growth in each well was compared with that of the growth control.  
The MIC for Amphotericin B is the lowest concentration with a 
score of 0 (optically clear). The MICs for the azoles are the lowest 
concentrations with a score of 2 (prominent decrease in turbidity).  
Interpretive MIC in µg/ml 
Drug  Susceptible 
     
SDD* 
 
Intermediate 
 
Resistant 
 
 
 Fluconazole 
 
     <8 
 
16-32 
 
- 
 
>64 
 
Itraconazole 
 
<0.125 
 
0.25-0.5 
 
- 
 
>1 
 
Amphotericin B 
 
0.5 
 
- 
 
- 
 
2 
SDD*-Susceptible dose dependent 
 Minimum Inhibitory Concentration by Hi comb strips: 
    Hi comb MIC is based on the principle of disc diffusion.       
Hi comb strip consists of a predefined and continuous concentration 
gradient of antifungal agent and therefore directly measures the 
discrete MIC values similar to that of broth dilution results. Advantage 
is that  Hi comb MICs are unaffected by molecular weight, aqueous 
solubility, diffusion and other propreties of the drug or by varying 
growth rates of  yeast.The procedure was performed similar to that of 
disc diffusion except that Hi comb strips were placed instead of discs.  
 
Antibiotic susceptibility test for Candida 
 
 
Microbroth dilution for Candida albicans 
 
 
MIC for Flu-8 µg/ml, Itr-0.25 µg/ml and Amp B-0.25 µg/ml 
Amp B 
Flu 
Itr 
  
Hi comb MIC test for Candida albicans 
 
 
MIC for Fluconazole- 0.64 µg/ml 
 
 
 
 
 
 
 
For Amphotericin B, reading was taken at complete inhibition of 
all growth. For Azoles, reading was taken at first point of significant 
inhibition i.e.so-called 80% inhibition. 
Cervical Swab 1: was subjected to Gram stain. 
Niesseria gonorrhoeae: The smear was examined for epithelial 
cells, polymorphonuclear leucocytes(PMNs), organisms and their 
location whether extracellular or intracellular. The gonococci are 
intracellular; bean shaped and are usually arranged in pairs, 0.8m x 
0.6m in size. They are Gram negative in reaction and are stained pink 
along with the pus cells. Intracellular diplococci atleast 3 pairs or more 
is strongly suggestive of Neisseria gonorrhoeae and the slide was 
examined for at least 2 minutes before declaring as negative.  
Chlamydial cervicitis: Presence of  >30 PMNL/ High power 
field with no gram negative diplococci and occasional bacteria is an 
indirect clue for Chlamydial cervicitis.66 
Cervical Swab 2: was inoculated in “ Z”  pattern, and then cross 
streaked with a sterile platinum/ nichrome loop on Chocolate agar and 
Modified Thayer Martin medium with VCNT (Vancomycin to inhibit 
gram positive bacteria, Colistin to inhibit gram negative bacteria, 
Nystatin to inhibit yeasts and moulds, Trimethoprim to inhibit  
Gram stain of Endocervical smear showing Intracellular Gram 
negative diplococci 
 
Cervical gram stain showing pus cells under oil immersion field 
 
 
swarming of Proteus) and incubated at 370C in 5-10%  Co2 
atmosphere. A moist cotton ball/ wet paper towel was placed inside the 
jar to provide >70% humidity and a lighted candle to provide 5% CO2. 
The plates were examined after 18-24 hours and incubated for another 
24 hours if there was no growth and re examined after 48 hours. Small 
pin point, 0.5 to 1 mm in diameter, grey to white in colour, smooth, 
translucent, raised convex colonies suggests Neisseria. 
Presumptive identification of Neisseria gonorrhoeae: 
1. Gram staining: Gram stain was done from smear prepared from 
suspected colony and it showed typical Gram negative 
diplococci. 
2.  Oxidase test:  
Method I (Direct colony method): 
1% fresh solution of oxidase reagent (N,N-Tetra methyl 
paraphenylenediamine dihydrochloride) was prepared by dissolving 10 
mg of reagent in 1 ml of distilled water.One drop of the reagent was 
added on the colony to be tested. Development of purple colour within 
10 seconds indicates that the isolate is propably Neisseria 
gonorrhoeae. 
Culture of N.gonorrhoeae on chocolate agar 
 
‘Z’ Streaking of Endocervical swab on Modified Thayer Martin 
medium 
 
Method II (Wet filter paper method): 
A filter paper strip was moistened with 2-3 drops of oxidase 
reagent. A single colony was picked with the wooden applicator stick, 
tip of glass slide, glass rod or platinum loop and rubbed on filter paper. 
Production of purple colour means positive result. 
Method III (Dry filter paper method): 
Whatman filter paper was cut into small strips and 1% fresh 
solution of oxidase reagent was poured on to the strips placing it in a 
petri dish and dried in hot air oven. The strips were stored in a brown 
bottle in refrigerator and tested with the suspected colony. 
i. Dark deep purple colour in 5 – 10 sec – positive test 
ii. Deep purple colour in 10 – 60 sec – Delayed positive test 
iii. No colour or colour development after 60 sec – negative test 
The test was performed with positive control (Pseudomonas 
aeroginosa ATCC 27853) and negative control (Escherichia coli 
ATCC 25922) 
Culture smear of N. gonorrhoeae showing Gram negative 
diplococci 
 
 
 
Oxidase test positive -Direct colony method 
 
3) Superoxol test: 
 Method I( Slide method): 
A drop of 30% w/v hydrogen peroxide was placed in the centre 
of a clean glass slide. Few colonies of the culture to be tested were 
picked with a glass rod and emulsified directly in the drop of hydrogen 
peroxide. 
Method II(Plate method): 
One drop of 30% w/v hydrogen peroxide solution was put on the 
suspected colony on chocolate agar. Immediate production of bubbles 
(within 1 to 2 seconds) was defined as a positive result. A negative 
reaction was defined by weak or delayed bubbling after 3 seconds. A 
negative test means that the isolate is not Neisseria gonorrhoeae. 
Confirmatory test for Neisseria gonorrhoeae: 
Rapid carbohydrate utilization test (RCUT): 
This is the most frequently used method for confirmation of 
Neisseria gonorrhoeae. This method is non-growth dependent and 
combines the use of carbohydrate utilisation and acidometric test for 
detection of beta-lactamase. Ampicillin is more stable and more 
sensitive to TEM -lactamase, was used instead of penicillin G in this 
test. 
Procedure: Pure culture of suspected Neisseria gonorrhoeae was 
obtained by sub culturing a single colony into Chocolate agar. Two full 
3 mm loop ful of the isolate of 24 hr pure culture was emulsified into a 
tube containing 0.3 to 0.4 ml buffered balanced salt solution (BSS). Six 
wells of a microtiter plate were required for each test. First well serves 
as control. 100 micro litre of BSS was added to all the wells, followed 
by 50 micro litre of 10% sterile glucose, maltose, sucrose, lactose and 
ampicillin solution to the respective wells. Finally, 50 micro litre of 
bacterial suspension was added to each of the five wells except the 
control. The wells were incubated aerobically at 37°C and read after 2 
to 4 hrs. 
Results:  Control tube/well   = Red 
               Positive reaction    =Yellow colour 
               Negative reaction   = Orange Red colour  
Only the tube containing glucose showed colour change, since 
Neisseria gonorrhoeae utilizes glucose only. 
 
 
 
 Sugar utilization reactions of Neisseria species 
Species Glucose Maltose Lactose Sucrose 
    N.cinera - - - - 
N.gonorrhoeae A - - - 
N.meningitidis A A - - 
N.lactamica A A A - 
 
 c) Antimicrobial susceptibility testing methods: 
The following antibiotics recommended by WHO were used for 
sensitivity testing. 
Penicillin,Ciprofloxacin,Tetracycline,Spectinomycin,Azithromycin,Cef
triaxone or other cephalosporins and test performed following CLSI 
guidelines.  
Neisseria gonorrhoeae colonies were picked up and emulsified 
in 5ml of phosphate buffered saline (PBS) to attain 0.5 Mc Farland’ s 
standard which corresponds to 150 million organisms/ml. 2 ml of 
colony suspension was poured on the plate with a sterile pasteur 
pipette. Then the plate was tilted in all directions to spread the 
inoculum over the entire surface of plate and the excess fluid was 
aspirated using a pasteur pipette. The plate was inverted and kept in the 
incubator at 37o C for 30 min for the inoculum to dry. After placing the 
discs, the plate was incubated at 37o C in Co2 atmosphere for 18-24 
hours. The diameter of the zones of complete inhibition was measured 
and were interpreted by referring to the CLSI standards and reported as 
susceptible, intermediate, or resistant to the antibiotics that have been 
tested. 
The three isolates of Neisseria gonorrhoeae were sent to the Apex 
Regional STD Teaching, Training and Research centre, Vardhaman 
Mahavir Medical College and Safdarjung Hospital and confirmed. 
 Zone size interpretative chart (CLSI) 
         Drug        Resistant 
(mm) 
Intermediate 
(mm) 
Sensitive 
(mm) 
Penicillin 10 U 26 27-46 47 
Tetracycline 
30ug 
30 31-37 38 
Spectinomycin 
100ug 
14 15-17 17 
Ceftriaxone 30ug 25 26-30 31 
Ciprofloxacin 
5ug 
27 28-40 41 
Azithromycin 
15ug 
25 - - 
Rapid Carbohydrate Utilisation Test(RCUT)-Only Glucose was 
utilised 
 
Antibiotic sensitivity test for N.gonorrhoeae 
 
 Cefur 
Spec 
Azi Tet 
Cip 
P 
The sensitivity test results of Reference centre done by Calibrated 
Dichotomous sensitivity method using Low potency discs were 
compared with that of CLSI method of our College.  
CLSI method (Stanley medical college) and CDS method (Regional 
reference centre) for 3 isolates of N.gonorrhoeae 
 
DRUG 
CLSI  CDS 
Sensitive 
(mm) 
Resistant 
(mm) 
Sensitive 
(mm) 
Resistant 
(mm) 
Penicillin 1 2 2 1 
Tetracycline 2 1 3 0 
Spectinomycin 3 0 3 0 
Ceftriaxone 2 1 3 0 
Ciprofloxacin 2 1 2 1 
Azithromycin 3 0 3 0 
 
CLSI-Central Laboratory Standards Institute, CDS-Calibrated 
Dichotomous sensitivity test 
Serum for Indirect ELISA for IgM, IgG antibodies to Chlamydia 
trachomatis (Novalisa-Germany) 
Procedure: 
 Dilute the samples by adding 1mL sample diluent to10 L of sample. 
                                             
Dispense 100L controls & diluted samples into their respective wells.  
                       Well A1 was left for Blank          
                                            
Cover microtitre plate with foil and incubate at 37°C for one hour. 
                                            
 Wash the wells three times, each with 300L of washing solution.  
                                            
Dispense 100L Chlamydia trachomatis anti Ig conjugate into all wells  
except the blank.   
                                            
Incubate at room temperature for 30 min. Do not expose to direct 
sunlight.  
                                            
Repeat the wash step three times.  
                                            
Dispense 100L TMB substrate solution into all wells including 
 blank.  
                                            
Incubate at room temparature for 15 min in dark. 
                                            
Dispense 100L stop solution into all wells including blank.  
 
IgM ELISA Kit for Chlamydia trachomatis 
 
 
IgM ELISA for Chlamydia trachomatis 
 
IgG ELISA Kit for Chlamydia trachomatis 
 
 
IgG ELISA for Chlamydia trachomatis 
 
The absorbance value was read immediately at 450/620 nm after 
addition of stop solution.The values above and below cut off were 
considered positive and negative respectively and  for subjects whose 
values fall in grey zone,the result needs to be repeated after 1 month. 
Consent was obtained from each patient for HIV testing and pre 
test counselling was given.Tests for HIV was done according to 
National AIDS Control Organisation (NACO) guidelines and Rapid 
Plasma Reagin test for syphilis was also performed.  
Tzanck smear: The vesicle is unroofed and the base of the 
lesion is scraped with the edge of scalpel blade. The material is then 
touched to a glass slide, air dried is then stained with Giemsa stain 
 
 
Tzanck smear under oil immersion showing multinucleated giant 
cells 
 
 
 
 
 
 
 
 
 
 
 
Multi 
nucleated 
giant cell 
OBSERVATION AND RESULTS 
Total number of patients studied was 130, which included 65 
High risk females with subjective vaginal discharge (Symptomatics), 
20 High risk females with objective vaginal discharge 
(asymptomatics), 35 Low risk females with subjective vaginal 
discharge (Symptomatics) and 10 Low risk females with objective 
vaginal discharge (asymptomatics). The results were analysed and 
tabulated as follows. 
 
Table 1:Distribution of females into groups based on risk and 
symptoms 
Symptom High risk Low risk Total % 
Subjective 
vaginal 
discharge 
 
65(50.0%) 
 
35(26.92%) 
 
100 
    
       76.92 
Objective 
vaginal 
discharge 
 
20(15.38%) 
 
10(7.69%) 
 
30 
 
23.07 
Total 85 45 130 34.61 
% 65.38 34.61 100 100 
 
 
Table 2:Age distribution of High risk and Low risk groups 
 
   Age(years) 
High risk Low risk 
Number % Number % 
15-19 0 0 0 0 
20-29 23 27.05 13 28.88 
30-39 48 56.47 26 57.77 
40-49 14 16.47 6 13.33 
Total 85 45 
Mean+SD 34.0±7.5 31.4±6.7 
 
Significance 
                                 t value=1.932  
  degree of freedom=128 
                                 P value >0.05 
 
Commonest age group in both high risk and low risk groups was 30-39 
years of age. The two groups were similar in age group distribution and 
did not show significant difference with respect to age (P>0.05) and 
therefore the two groups were comparable.  
Figure 1:Distribution of females into groups based on risk and 
symptoms 
 
 
 
 
Figure 2:Age distribution of High risk and Low risk groups 
 
 
 
Table 3:Distribution of subjects based on Educational status 
 
Education 
High risk Low risk 
Number % Number % 
Nil 32 37.64 13 28.88 
Primary school 21 24.70 10 22.22 
Middle school 23 27.05 16 35.55 
High school 7 8.23 5 11.11 
Higher 
secondary 
2 2.35 0 0 
Degree 0 0 1 2.22 
Total 85 100 45 100 
 
Significance 
                               
2 
=
   3.156 
 degree of freedom = 5 
                              P>0.05 
 
          Commonest educational level in high risk group was nil 
education and low risk group was middle school level. But statistically 
the two groups did not show significant difference with respect to 
Educational status (P>0.05) and therefore both groups were 
comparable in education level. 
Table 4:Distribution of subjects based on Marital status  
Marital status High risk % Low risk % 
Unmarried 1 0.11 0 0 
Married 74 87.05 43 95.55 
Widow 5 5.88 1 2.22 
Separated 5 5.88 1 2.22 
Total 85 100 45 100 
 
Significance 
                          
2 
=
  4.353 
                 degree of freedom = 4 
                           P>0.05 
 
Married women the commonest of about 87.05% in high risk 
and 95.5% in low risk group. The two groups did not show significant 
difference with respect to Marital status (P>0.05). 
 
 
 
 
Figure 3: Distribution of subjects based on Educational status 
 
 
 
Figure 4: Distribution of subjects based on Marital status 
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Table 5: Distribution of Protected/ Unprotected sex in high risk 
group 
Sexual Contact Number % 
Protected 46 54.11 
Unprotected 37 43.52 
No recent contact 2 2.35 
Total 85 100 
     About 43.52% females in high risk group followed unprotected sex. 
Table 6:Distribution of risk factors  
Risk factor (n=130) Number % 
Female sex worker 23 17.69 
House wife with 
extramarital contact 
28 21.53 
Diabetes and steroid 8 6.15 
Past VD 14 10.76 
Partner HR 18 13.84 
Low risk 45 34.61 
 
         The most common risk factor was housewives with extramarital 
contact (21.53%) 
Figure 5: Distribution of sex among high risk group based on 
protection 
 
 
Figure 6: Distribution of risk factors in high risk group 
 
 
 
BACTERIAL VAGINOSIS: 
Table 7: Amsel criteria  
Amsel Number % 
3 46 35.38 
<3 84 62.22 
Total 130 100 
 
            Amsel was significant in 35.38% of females studied. 
 
Table 8:Nugent scoring: 
Nugent score Number % 
<4 68 52.30 
4-6 43 33.07 
7 19 14.61 
Total 130 100 
            Nugent score was suggestive of Bacterial vaginosis in 14.61% 
of females studied. 
 
Table 9: Culture positivity of Gardnerella and Anaerobes : 
Culture Number % 
Positive 21 16.15 
Negative 109 83.89 
Total 130 100 
          Culture was positive in 16.15% of females 
Table 10:Comparison of  positivity by Amsel, Nugent and Culture 
n=130 Amsel Nugent Culture  2 Value 
High 
risk(85) 
29 12 16 0.803 p>0.05 
Low 
risk(45) 
17 7 5 
Total 
n=130 
46 19 21 
% 35.38 14.61 16.15 
 
            All the three methods detected positives more in high risk 
group. Among the three methods Amsel identified more positives than 
other two methods. 
Figure 7: Comparison of positivity by Amsel, Nugent and Culture 
for Bacterial vaginosis 
 
 
 
 
 
 
 
 
 
TRICHOMONIASIS 
Table 11:Comparison of  positivity by Wet mount, Giemsa and 
Culture  
n=130 Wet Giemsa Culture  2 Value 
High risk (85) 5 4 6 1.125 P>0.05 
Low risk (45) 2 1 2 
Total  7 5 8 
% 5.38 3.84 6.15 
 
           The detection of positivity by Culture was more compared to 
Wet mount and Giemsa stain.  
VULVOVAGINAL CANDIDIASIS 
Table 12:Comparison of positivity by KOH,Gram stain,Culture 
n=130 KOH Gram Culture  2 Value 
High risk (85) 24 26 36 11.021 P<0.05 
Low risk (45) 12 15 15 
Total (n=130) 36 41 51 
% 27.69 31.53 39.23 
 
            The detection of positivity by Culture was more and 
statistically significant than KOH mount (P<0.001). 
Figure 8: Comparison of positivity by Wet mount, Giemsa and 
Culture for Trichomoniasis 
 
 
Figure 9:Comparision of positivity by KOH, Gram stain & 
Culture for Candidiasis 
 
 N.GONORRHOEAE 
Table 13:Comparison of positivity by Gram stain and Culture 
n=130 Gram Culture Z Value 
High risk (85) 3 3 0.0 P=1.00 
Low risk (45) 0 0 
Total (n=130) 3 3 
% 2.30 2.30 
           Positives were seen only in high risk group and both the 
methods detected equal number of positives in our study.  
CHLAMYDIA TRACHOMATIS 
Table 14:Comparison of  positivity by Gram stain (number of pus 
cells) and Serology (ELISA) 
n=130 Gram Serology Z Value 
High risk (85) 17 32 2.368 p <0.05 
Low risk (45) 7 9 
Total (n=130) 24 41 
% 15.38 31.53 
          Serology identified more positives and was statistically 
significant in the low risk group (P<0.05). 
 
Figure 10: Comparison of positivity by Gram stain and Culture for 
Gonococcal cervicitis 
 
 
Figure 11: Comparison of positivity by Gram stain and Serology 
for Chlamydial cervicitis 
 
 AEROBIC BACTERIA 
Table 15:Comparison of positivity by Gram stain and Culture: 
n=130 Gram Culture Z Value 
High risk (85) 8 9 0.57 p>0.05 
Low risk (45) 2 2 
Total (n=130) 10 11 
% 7.69 8.46 
            Aerobic bacteria isolated were Staphylococcus aureus 3, Group 
A Streptococcus 2, Group B Streptococcus 2, Escherichia coli 3, 
Enterococci 1. 
Table 16: Comparison of total result among high risk and low risk 
group 
Results High 
risk 
(85) 
Low 
risk 
(45) 
Total 
(130) 
  % 2 Df Significance 
Positives 74 26 100 76.92 16.08 1 P<0.001 
Negatives 11 19 30 23.07 
Total 85 45 130 100 
 
Out of 130 females studied, 100 (76.92%) of them showed 
positive for pathogenic isolates.  Total positives were more in high risk 
than low risk group. 
Figure 12: Comparison of positivity by Gram stain and Culture for 
Aerobic vaginosis 
 
 
 
 
 
 
 
 
 
 
 
Table 17: Multiple isolates positivity among highrisk and lowrisk 
group 
Results High 
risk(85) 
Low 
risk(45) 
Total 
(130) 

2
 Df Significance 
Mixed 
infection 
30 10 40 2.985 1 P>0.05 
Single 
infection 
44 16 60 
Total  
positive 
74 26 100 
            Mixed infections were seen in 40 (40%) of total positives, more 
in high risk than low risk group. 
Table 18: HIV, RPR reactivity & Tzanck smear positivity: 
 
Total(n=130) 
 
Reactive 
 
Non reactive 
 
Not tested 
  HIV 7(5.38%) 120(92.30%) 3(2.30%) 
  RPR 3(2.30%) 124(96.92%) 3(2.30%) 
 Tzanck  4(3.07%) 1(0.7%) 125(96.15%) 
             HIV, RPR reactivity and Tzanck smear positivity were seen 
exclusively in high risk group. 
 
 
 
Figure 13:HIV reactivity 
 
 
 
 
Figure 14:RPR reactivity 
 
 
 
                                Figure 15:Tzanck smear positivity 
 
 
 
 
 
 
 
 
 
 
Table 19:Total number isolates among high risk and low risk 
groups 
Isolates High risk Low risk Total % 
Gardnerella 
&Anaerobes 
16 5 21 14.38 
Trichomonas 
vaginalis 
6 2 8 5.47 
Candida 42 17 59a 40.47 
N.gonorrhoeae 3 0 3 2.05 
Chlamydia 32 9 41 28.08 
Aerobic bacteria 9 2 11 7.53 
Herpes Simplex Virus 4 0 4 2.73 
Total 112*(76.71%) 34*(23.77%) 146* 100% 
            *Total number of isolates grown in Culture was more than the 
total number of patients studied, since multiple isolates were obtained 
from 30 high risk and 10 low risk individuals. aIn 8 patients with 
Candidiasis, more than one species of Candida was grown in Culture.  
       The Commonest etiology was Candida followed by Chlamydia 
trachomatis, Gardnerella vaginalis and anaerobes, Aerobic bacteria, 
Trichomonas vaginalis and Neisseria gonorrhoeae in order. Isolation 
of pathogens were more in high risk compared to low risk group. 
 
Table 20:Follow up after treatment 
Syndromic 
management(n=120) 
                N % 
Responded 105 87.5 
Not responded 15 12.5 
 
         Out of 120 patients treated on the day of visit, 87.5% showed 
relief of symptoms and 12.5% continued to have symptoms. 
Table 21: Co infection 
Multiple 
Etiology(n=40) 
Number % 
Vaginal+ cervical 15 37.5 
Multiple vaginal 11 27.5 
Multiple cervical 0 0 
Discharge 
etiology+HIV 
7 17.5 
Discharge 
etiology+RPR 
3 7.5 
Discharge 
etiology+Tzanck 
4 10 
Total 40 100 
              Combined vaginal and cervical etiologies were identified in 
37.5% of those who showed multiple etiologies. 
Figure 16: Total isolates among high risk and low risk groups 
 
 
Figure 17: Follow up after treatment 
 

 
 
Table 22:Sensitivity pattern of isolates 
 
Isolate (n) 
 
       Sensitive (%) 
 
Resistant (%) 
 
Gardnerella 
vaginalis 
(11) 
 
 Penicillin (19.0%) 
 Metronidazole (100%) 
 Vancomycin (100%) 
 
Penicillin (81.81%) 
Metronidazole (0%) 
Vancomycin (0%) 
 
Anaerobic 
bacteria 
(10) 
 
Penicillin (30%)  
Vancomycin (80%) 
Metronidazole (100%)  
 
Penicillin (70%) 
Vancomycin (20%) 
Metronidazole (0%) 
 
Aerobic 
bacteria 
(11) 
 
Co-trimoxazole (19.0%) 
Penicillin (28.28%) 
Gentamicin (28.28%) 
Cefataxime (0%) 
Amikacin (0%) 
 
Co-trimoxazole (81.81%) 
Penicillin (72.72%) 
Gentamicin (72.72%) 
Cefataxime (0%) 
Amikacin (0%) 
 
Candida 
(59) 
 
Itraconazole (83.06%) 
Fluconazole (93.3%) 
Amphotericin B (100) 
 
Itraconazole (16.94%) 
Fluconazole (6.77%) 
Amphotericin B (0%) 
 
Neisseria 
gonorrhoeae 
(3) 
 
Penicillin (66.67%) 
Ciprofloxacin (66.67%) 
Azithromycin (100%) 
Spectinomycin (100%) 
Ceftriaxone (100%) 
 
 
Penicillin (33.33%) 
Ciprofloxacin (33.33%) 
Azithromycin (0%) 
Spectinomycin (0%) 
Ceftriaxone (0%) 
 
 
           Anaerobic isolates showed reistance to penicillin to a greater 
percentage, but metronidazole remained sensitive. Aerobic isolates 
showed resistance to co-trimoxazole in higher percentage. Among 
candida isolates resistance to Itraconazole (16.94%) was more than 
Fluconazole and Amphotericin B and 33.33% N.gonorrhoeae were 
resistant to Penicillin and Ciprofloxacin. 
DISCUSSION 
STIs rank the fourth common health problem in the global 
scenario, with an annual incidence exceeded only by diarrheal diseases, 
malaria and lower repiratory tract infections.  In the developing world, 
STIs are one among the important causes of disability adjusted life 
years (DALYs) lost for women of sexually active age group, next to 
maternal causes and HIV. 
In the present study, out of 130 female patients studied, 
85(65.38%) were found to be highrisk individuals and 45(34.61%) 
were low risk individuals.Among the total patients studied, 100 
(76.92%) of them had subjective vaginal discharge and 30(23.07%) of 
them had objective vaginal discharge (Table 1).This is similar to the 
observation in a study done by A Das et al 3 in which 68% were 
symptomatics and 32 % were asymptomatics. 
 The females in our study belonged to15-49 years (sexually 
active) age group since this is the age group that is vulnerable for STIs. 
The age group of the population in our study was categorised based on 
decades and was found that, about 48(56.47 %) females in the highrisk 
group and 26(57.77%) females in the low risk group belonged to 30-39 
years of age group. In our study 30-39 years was the commonest age 
group affected.  A study done by Madeline Sutton et al 48 showed that 
eventhough 15-20 years was the most common age group affected  in 
their study (32%), positives were detected more in 30-39 years age 
group which comprised to about 20% of their study population. The 
mean age was 34.0±7.5 years in high risk group and 31.4±6.7years in 
lowrisk group (Table 2).This is similar to the age group finding of 
31.1+6.9 years in study done by Ros anarlu 59 and is different from the 
mean age of 28±0.2 years in another study 28.  
                   Analysis of educational status of the females in our study 
showed that illiterates were more common in highrisk group (37.64%) 
compared to lowrisk group (28.88%). About 35.55% of females in 
lowrisk group had middle school level of education (Table 3). The 
percentage of illiterates in our study was higher than 26% seen in a 
study conducted in Mysore district of Karnataka by P Madhivanan 
etal54. The reason for difference in percentage of illiterates of our study 
and the other study may be due to the difference in literacy rates 74of 
the two states and the difference in study population. Madhivanan et al 
study was focussed on females of general population, our study was 
focussed on high risk females which included sex workers. Sexworkers 
of our study   gave lack of education and income as one of the reasons 
for entering sex work, which is supported by the report of study done 
by Z Fiona scorgie et al.76 
Married women were common in both the groups but widows 
and separated females were more in high risk group 5.88% each 
compared to low risk group (2.22%)(Table 4). Similar percentage of 
widows and separated females (8.45%) was seen in study conducted by 
Madeline Sutton et al.48 
               In the present study, unprotected sex was carried out by 
43.52 % of females (Table5). In the study done by A Das et al, the 
percentage of unprotected sex was found to be 70%, which is better 
than our observation. This emphasis the need for creating awareness 
regarding protective measures through health education campaigns 
among population subgroups especially commercial sex workers.  
The most common high risk factor seen was housewife with 
extramarital contact followed by professional sex worker, female with 
highrisk partners, past venereal disease, diabetes and steroid intake in 
order (Table 6). 
In the present study, Amsel criteria identified 35.38%of positives 
(Table 7) which is similar to a study by Aggarwal et al1 where Amsel 
positivity was 40%1.In our study, Nugent score detected 52.30% as 
having normal flora, 33.07% as having intermediate flora and 14.61% 
are diagnosed as bacterial vaginosis (Table 8). A study conducted by P 
Madhivanan et al54 showed 65.4% had normal flora, 15.4% had 
intermediate flora and 19.1% had bacterial vaginosis which supports 
the observation of our study. Culture detected 16.15% in our 
study(Table 9) which correlates well with the study by PS Rao et al55 
where culture positivity was 17.42%. 
          For diagnosis of bacterial vaginosis, positivity by Amsel’s 
criteria (35.38%) was more than Culture (16.15%) followed by Nugent 
scoring (14.61%) (Table10). A study by Marijane et al50 showed 
Culture detected more positives followed by Amsel and Nugent in 
order. Initial difficulties faced in isolation of Anaerobes could be the 
reason for the lower percentage of culture positivity in our study.   
                    For Trichomoniasis, Culture (6.15%) identified more cases 
than Wet mount (5.38%) than Giemsa stain (3.84%) (Table 11). The 
order of sensitivity of three methods of our study correlates well with 
the findings of the study done by Akujobi et al5 where the culture 
(9.04%) was more sensitive than wet mount (8.01%) than Giemsa stain 
(6.71%) eventhough the positive percentage by all the three methods 
were slightly lower in our study. The reason could be due to variation 
in prevalence in various geographical areas. 
 
For vulvovaginal candidiasis, culture (39.23%) identified more 
cases than gram stain (31.53%) than KOH mount (27.69%) (Table 
12).This finding is supported by a study by Mirela et al53 where culture 
detected 25.4% cases which is more than microscopy 
positivity(23.8%). 
For Gonococcal cervicitis, both gram stain (2.30%) and 
culture(2.30%) detected equal number of cases(Table 13). Our study 
showed gram stain detected 100 % of cases identified by culture which 
is different from the study done by knud Hansen et al38 showed 
endocervical gram stain had 47% sensitivity to diagnose gonococcal 
cervicitis. 
For Chlamydia, Serology (31.53%) identified more cases than 
Gram stain (15.38%) (based on number of pus cells in endocervical 
smear) (Table 14) .The reason could be due to the low sensitivity of 
Microscopy (17%) shown in a study done by Linda Myziuk45and non-
specificity of ELISA, since the antigen used was LPS 
(Lipopolysaccharide), non-specific antigen which may give false 
positive result with  any LPS containing organism.  
For Aerobic vaginosis, Culture (8.46%) detected more cases than 
Gram stain (7.69%) (Table 15). Though the aerobic bacteria were not 
sexually transmitted, they have been implicated as causative agents of 
vaginal discharge.A study conducted by Gilbert et al 25 showed Culture 
positivity was 17% compared to the smear positivity of 7.9% which 
correlates with the order of sensitivity of the two methods in our study.  
Out of 130 females studied, etiological agents of cervicovaginal 
discharge was identified in 100 (76.92%) females.  Females in high 
risk group yielded more positives than females in low risk group. 
Multiple isolates was seen in 40 (40 %) of positives, which is more in 
high risk group than lowrisk group(Table 16 &17). 
In our study, HIV reactivity was found to be 5.38% , RPR 
(Rapid Plasma Reagin) reactivity was 2.30%, Tzanck smear positivity 
suggestive of Herpes simplex was 3.07%(Table 18). Genital herpes 
was diagnosed based on Tzanck smear only due to non availability of 
Herpes serological tests during the test period The detection of HIV in 
patients with STI is important since they are at increased risk of getting 
HIV because of common mode of transmission for STI and HIV and 
also due to the reason that any STI increases the acquisition and 
transmission of HIV and the chances of acquiring STI in presence of 
HIV is also increased.  
The total number of isolates obtained was 146, of which 112 
(76.71%) isolates were in high risk group and 34 (23.77%) isolates 
were in the low risk group. The percentage of various isolates in our 
study were candidia 40.47%,Chlamydia trachomatis 28.08%, 
Gardnerella vaginalis and anaerobes 14.38%,Aerobic bacteria 
7.53%,Trichomonias vaginalis 5.47 % and N.gonorrhoeae 2.05% 
(Table19).In a study by PS Rao55 among reproductive age group 
women in rural areas ,the prevalence of  vulvovaginal candidiasis was 
10.69%,Bacterial vaginosis was 17.42%,Trichomoniasis was 1.18%, 
Gonococcal cervicitis was 0%. In a study conducted among female sex 
workers in Mumbai and Hyderabad 3, the prevalence of bacterial 
vaginosis was found to be 67.38%, Trichomoniasis 29.73%, 
Vulvovaginal candidiasis was 20.38%, Gonococcl cervicitis was 
14.14% and Chlamydial cervicitis was 16.06%.The higher prevalence 
of positivity seen in Mumbai and Hyderabad could be due the reason 
that their study population were professional sex workers of redlight 
area. 
The follow up of patients showed that 87.5% of females showed 
complete relief of symptoms after treatment and 12.5% of females 
continued to have symptoms inspite of initial treatment given on the 
day of visit(Table 20) 
The results of microbiological techniques showed that the 
reasons for treatment failure were existence of more than one infection 
in many of those females and resistant isolates in a few. Complete cure 
was achieved on providing specific treatment. Coinfection with 
cervical and vaginal etiologies were identified in 37.5% females (Table 
21) suggesting that a combined treatment approach of vaginal 
discharge and cervicitis would be more useful for management of 
discharge syndrome in females.A study conducted by A Das et3 al had 
stated that female sex workers having vaginal discharge should be 
treated for both vaginal and cervical infectious etiology. 
 
 
 
In the present study, about 70% of Gardnerella vaginalis and 
anaerobes were resistant to penicillin, aerobic isolates were resistant to  
cotrimoxazole, penicillin and gentamicin, 16.94% of Candida isolates 
were resistant to Itraconazole and 33.33% of N.gonorrhoeae were 
resistant to penicillin and ciprofloxacin (Table 22). 
Establishing an etilogical diagnosis helps to identify all 
etiological agents in coinfections thus helping to achieve complete 
cure. Also isolation of pathogen is essential for susceptibility testing in 
resistant and recurrent cases. Therefore the possibility of co infections 
and resistant pathogen should always be considered, atleast in 
treatment failure cases, which emphasises the need for isolation of the 
pathogen and susceptibility testing.  
 
 
SUMMARY 
This study was conducted to find out the prevalence of various 
etiological agents responsible for cervico vaginal discharge and to 
evaluate syndromic,clinical and etiological diagnosis.Total of 130 
female patients were studied which included 85 high risk and 45 low 
risk females. 
The various etiological agents of cervico vaginal discharge 
found were Vulvovaginal candidiasis 40.47%, Chlamydial cervicitis 
28.08%, Bacterial vaginosis 14.38%, Aerobic vaginosis 7.53%, 
Trichomoniasis 5.47% and Gonococcal cervicitis 2.05%.The 
prevalence of the all the etiological agents were found to be higher in 
high risk group compared to the low risk group. 
For diagnosis of Bacterial vaginosis, Amsel’ s criteria detected 
more positives than Culture and Nugent score. For Trichomoniasis, 
culture identified more cases than wet mount and Giemsa stain. For 
Vulvovaginal candidiasis, Culture was better than Gram stain and 
KOH mount. For Gonococcal cervicitis, both Gram stain and Culture 
detected equal number of cases in our study. For Chlamydial cervicitis, 
Serology identified more cases than Gram stain. For Aerobic vaginosis, 
Culture was better than Gram stain. 
Coinfections were seen in 40% of positives and combined 
cervical and vaginal infections were seen in 37.5 % of Coinfections. So 
this study suggests a combined approach of treating female patients for 
both vaginal discharge and cervicitis syndrome. HIV test reactivity was 
found to be 5.38% among the total study population  
 Anaerobic bacterial isolates showed resistance to penicillin, but 
were sensitive to Metronidazole. Aerobic isolates were resistant to Co-
trimoxazole. Candida isolates showed resistance to Itraconazole more 
than Fluconazole and Amphotericin B. Neisseria gonorrhoeae showed 
resistance to penicillin and ciprofloxacin but third generation 
cephalosporins remained sensitive. 
Syndromic management was successful in 87.5% of treated 
female patients and thus it can be considered as the treatment method 
in resource poor settings. Etiological diagnosis was considered as a 
better diagnostic approach than syndromic or clinical diagnosis which 
was evident from the outcome of 12.5% treatment failure cases, who 
showed complete relief of symptoms only after specific treatment was 
given, in addition to the initial syndromic management.  
 
CONCLUSION 
This work was done to study the various aspects of Cervico 
vaginal discharge and found that among the various etiologies of 
cervico vaginal discharge, Candidiasis was the commonest  followed 
by Chlamydial cervicitis,Bacterial vaginosis,Aerobic vaginosis, 
Trichomoniasis and  Gonococcal cervicitis in order. 
Amsel criteria for Bacterial vaginosis, Culture for 
Trichomoniasis, Vulvovaginal candidiasis and Aerobic vaginosis, 
Serology for Chlamydial cervicitis were the methods which showed 
greater sensitivity compared to other methods. For Gonococcal 
cervicitis, both Gram stain and Culture were equally sensitive. 
Coinfections were found in more than one third of total positive 
females suggesting a combined treatment method for vaginal and 
cervical etiologies. 
Resistance to penicillin and co-trimoxazole was seen among the 
bacterial isolates in higher percentage with Neisseria gonorrhoeae 
showing resistance to penicillin and ciprofloxacin. Resistance to 
Itraconazole was seen among candida isolates.  
Syndromic management still remains as the method of choice 
for treatment in resource poor settings. Etiological diagnosis should be 
achieved wherever laboratory facilities are available in order to 
minimise treatment failure to prevent complications and disease 
spread. Thus Etiological diagnosis and appropriate management helps 
to achieve complete cure and prevent complications including 
infertility, malignancy and easy acquisition of HIV. Since high risk 
females form one of the core groups, effective treatment of these 
females, contact tracing, partner treatment and Health education to the 
high risk population can reduce the disease spread from core group to 
the general population significantly. 
 
 
 
 
 
 
 
 
 
 
 
 
 
                                      APPENDIX 
 1.BLOOD AGAR 
Ingredients: 
Nutrient agar 100ml 
Sterile sheep blood 5 ml 
Procedure: 
Autoclave the nutrient agar base at 121°C for 15 minutes. 
Cool to 4550 ºC and add blood with sterile precautions 
and distribute in petri dishes. 
2.HUMAN BLOOD BILAYER TWEEN AGAR: 
 Columbia agar base  
 1% Proteose peptone 
Tween 80   0.00075% 
Amphotericin B  2.0 µg/ml 
Prepare Basal medium , add the supplements ,pour in petri plates and 
overlay with 5% human blood. 
 3.MODIFIED CYSTEINE PETONE LIVERINFUSION 
MALTOSE  MEDIUM 
Ingredients: 
Peptone 32 gms 
Maltose 1.6 gms 
LCysteine hydrochloride 2.4 gms 
Liver digest  20 gms 
Ringer’ s solution ,1/4 strength  1 lit 
NaOH 1mol/lit   0.9 ml 
Distilled water 900 ml 
1. Mix the contents in distilled water. 
2. Steam the medium at 100°C for 30 minutes. 
3. Adjust pH to 6.0 
Penicillin streptomycin solution: 
Penicillin  0.06 gms 
Streptomycin  0.1 gms 
Sterile water   10 ml 
Nystatin solution: 
Nystatin  5x104 units 
Sterile water  10 ml 
Procedure: 
Basal medium  90 ml 
Sterile horse serum 10 ml 
Penicillin streptomycin solution 1 ml 
Nystatin solution 1 ml 
Complete medium is prepared and distributed in sterile screw capped 
4.SABOURAUD’S DEXTROSE AGAR 
Ingredients: 
Neopeptone 10.0 gm 
Agar 15.0 gm 
Dextrose 40.0 gm 
Distilled water 1000 ml 
Procedure: 
1. Mix the ingredients in distilled water by boiling. Adjust pH to 5.6. 
2. Sterilize by autoclaving at 115° C for 15 min. 
3. Allow to cool to 50° C. 
4. Pour into 15 ml test tubes. 
5. Allow the test tubes to rest at an angle so that agar slopes (slants) are 
obtained. 
6. After the medium solidifies, cotton wool stopped dextrose agar 
slants in the refrigerator. 
5.CHOCOLATE AGAR 
Ingredients: 
Nutrient agar base 30 gm. 
Sheep blood 100 ml. 
Distilled water 1000 ml. 
Procedure: 
1.Dissolve 30 g of Columbia agar base to 1 litre of distilled water in a 
flask. 
Heat in a stem sterilizer to dissolve it completely. 
2.Adjust the pH to 7.5 – 7.6. 
3.Sterilize by autoclaving at 121° C for 15 minutes. 
4.Cool to 70° C in a water bath. 
5.Aseptically add 100 ml of sheep blood to it and leave at 70° C for 30 
minutes. 
6.Mix the blood and agar by gentle agitation from time to time till 
blood 
becomes chocolates brown in colour. This  will take about 10 minutes. 
7.Pour as slopes or plates in sterile tubes or sterile Petri dishes. 
6. MODIFIED THAYER MARTIN MEDIUM  
A selective medium for the isoltion of N. gonorrhoeae. 
Ingredients: 
1. Modified Thayer Martin agar base 21 gm 
2. 2% Hemoglobin solution 250 ml 
3. Distilled water 450 ml. 
4. VCNT inhibitor 10ml 
i).Vancomycin 2.0 to 4..0 mg or lincomycin 1 mg/litre 
ii. Colistin 300.000 units to 7.5 mg/litre 
iii. Nystain 12.5 IU/ml 
iv.Trimethoprim 2mg/litre. 
Procedure: 
1. Mix 21gms of MTM agar in 450 ml of distilled water by boiling. 
2. Sterilize by autoclaving at 121° C for 15 minutes. 
3. Cool to 5055° C in a waterbath. 
4. Aseptically add freshly prepared 250 ml of 2% hemoglobin solution 
and VCNT inhibitors and mix well. 
5. Pour 20 ml of medium in a sterile Petri dish of 90 mm diameter 
under strict aseptic precautions. 
6. Allow the medium to cool and store in refrigerator. 
7.BUFFERED BALANCED SALT INDICATOR SOLUTION 
(BSS) 
Ingredients: 
Dipotassium hydrogen phosphate 0.4 gms 
Potassium dihydrogen phosphate 0.1 gm 
Potassium Chloride 8.0 gms 
Phenol red indicator 0.6 gms 
Distilled water 1000 ml 
Procedure: 
1. Mix the salts and indicator in distilled water. 
2. Adjust the pH to 7.1 to 7.2. 
3. Sterilise by Seitz filter. 
4. Store in the refrigerator at 4°C. 
8. PHOSPHATE BUFFERED SALINE: 
Ingredients: 
NaCl 9.0 gm 
Potassium chloride 0.2 gms 
Disodium hydrogen phosphate 1.15 gms 
Potassium dihydrogen phosphate 0.2 gms 
Distilled water 1000 ml 
Mix the salts in distilled water.  
Adjust  the pH to 7.3. 
9. MUELLER HINTON Agar 
Ingredients: 
Beef Infusion 300.00 gms 
Casein acid hydrolysate 17.50 gms 
Starch 1.50 gms 
Agar 17.00 gms 
Distilled water 1000 ml 
Final pH at 25º C 7.3± 0.2. 
Procedure:Suspend 38 gms in 1000 ml distilled water. Heat to 
boiling to dissolve the medium completely. Sterilze by autoclaving 
at 15lbs pressure (121ºC) for 15 minutes. Mix well before pouring. 
Pour 2025ml of it into petridishes of 9cm diameter to give a thickness 
of 4 mm. 
 
 
 
 
 
 
 




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Name: 
Age: 
Address: 
STD OP number.: 
Micro ID no: 
Presenting complaints: 
Menstrual history: 
Sexual history: 
Personal history: 
H/O previous STD: 
H/O diabetes / Steroid intake: 
Treatment history: 
       For Past & present STD 
EXAMINATION  
General examination : 
Genital examination: 
Other system examination : 
INVESTIGATIONS: 
Discharge from speculum 
• AMSEL criteria 
Character of the discharge 
pH 
amine odour on addition of 10% 
KOH 
• Saline mount 
• KOH mount 
 
High vaginal swab 1: Gram stain: Nugent score 
                         Modified Donder’ s score 
High vaginal swab 2: culture for Gardenella vaginalis & 
Anaerobes 
High vaginal swab 3: culture for Trichomonas vaginalis 
High vaginal swab 4: culture for Candida  
Endocervical swab 1: Gram stain for cervicitis and 
intracellular diplococcic 
Endocervical swab 2: culture for Neisseria gonorrhae 
 
 Geimsa stain – Tzanck smear for Herpes simplex virus  
 
Serum for HIV testing 
                  ELISA – Chlamydia IgG &IgM antibodies 
                  Rapid plasma reagin test for syphilis 
 
Diagnosis: 
Drug kit given: 
Follow up: 
 
 
 
 
 
 
 
 
              
	


Sub dis-Subjective vaginal discharge 
Obj dis-Objective vaginal discharge 
FSW-Female sex worker 
Mul con-Multiple contact 
Last MC-last Marital contact 
Last EMC-last Extramarital contact 
Dia & ste-Diabetes and steroid intake 
Past VD-Past venereal disease 
Partn HR-Partner High risk 
HIV-Human Immunodeficiency virus infection 
RPR-Rapid plasma reagin test 
Wet-Wet mount 
KOH-KOH mount 
Ams-Amsel criteria 
Nug-Nugent score 
Giem-Giemsa stain 
GS- v,c smear-Gram stain of vaginal &cervical smear 
Ae.ba-Aerobic bacteria 
An.ba-Anaerobic bacteria 
P/A-Penicillin/Ampicillin 
E/G-Erythromycin/Gentamicin 
Co-Cotrimoxazole 
Ak-Amikacin 
M-Metronidazole 
V-Vancomycin 
Gono-Neisseria gonorrhoeae 
C-Ciprofloxacin 
T-Tetracycline 
Az-Azithromycin 
S-Spectinomycin 
Ce-Ceftriaxone 
TV-Trichomonas vaginalis 
F-Fluconazole 
I-Itraconazole 
Am-Amphotericin B 
GPC-Gram positive cocci 
GNC-Gram negative cocci 
GNB-Gram negative bacilli 
Yea-Yeast cells 
PSE-Pseudohyphae 
GV-Gardnerella vaginalis 
MOB-Mobiluncus 
Peptost- Pepto streptococcus 
E.coli-Escherichia coli 
S.aureus-Staphylococcus aureus 
NG-No growth 
S-Sensitive 
R-Resistant 
C.al-C.albicans 
C.pa-Candida parapsilosis 
C.kr-Candida krusei 
C.tr-Candida tropicalis 
C.gl-Candida glabarata 
Tzan-Tzanck smear 
Chla-Chlamydia trachomatis IgM,IgG 
 
 




 

S.no Name
Age
STD no
Sub 
dis
Obj 
dis FSW
Mul 
con
Last 
MC
Last  
EMC Dia & ste
Past 
VD
Partn 
HR HIV RPR Wet KOH Ams Nug Giem  Gs-v,c smear  Ae.Ba P/A Ci E/G Co
A
k Ce An.Ba P M V Gono P C T Az S
C
e TV Fungal F I Am Tzan  Chla
1 MEKALA 31 417/11 S no S NO 3 mon 7 days NO NO NO NR NR nil nil 3 7 neg nil NG NG NG NG NG neg neg
2 CHITRA
33
424/11 S no NO NO 7 days no NO NO S NR NR nil YEAST 1 3 neg
YEA,GNC 
PAIR NG NG Gono R R S S S S NG C.al s s s neg neg
3 LAKSHMI
45
472/11 S no NO S 1 yr 15 days NO NO NO NR NR nil nil 1 0 neg nil NG NG NG NG NG neg POS
4 INDIRA 28 474/11 S no NO S 2 yr 4days NO NO NO NR S,1:2 TV nil 3 4 pos nil NG NG NG TV C.gl s s s neg neg
5 FATHIMA
32
493/11 S no No S
14 
days no NO Syphi NO NR S,1:4 CLUE nil 4 8 neg PUS CELL NG Peptost R S S NG NG C.kr s r s neg POS
6 SARASWATHY 30 504/11 S no NO S 3 yr 1 day NO NO NO NR NR CLUE nil 3 4 neg nil NG NG NG NG NG neg neg
7 SHANTHI 30 505/11 S no NO S 15 4 mon NO NO NO NR NR CLUE nil 3 2 neg nil NG NG NG NG C.al s s s neg neg
8 SUSAIMARY
28
506/11 S no NO S NO 7 days NO NO S NR NR CLUE nil 3 5 neg nil NG GV S R S NG NG NG neg POS
9 KRISHNAVENI 45 710/11 S no NO NO 30 no NO NO NO S,ART NR nil YEAST 1 2 neg YEAST NG NG NG NG C.al ,C. gl s s s neg neg
10 ESTHER
44
292/11 S no NO S
10 
days 5 days S
OLD 
VVC NO NR NR nil YEAST,PS 1 5 neg YEA,PSEUDO NG NG NG NG C.pa,C.al s r s neg POS
11 BHUVANESWARI
33
227/11 S no NO NO
20 
days no NO NO NO S,ART NR CLUE nil 2 5 neg nil NG NG NG NG NG neg POS
12 KAVITHA
25
821/11 S no NO NO 5 days no NO NO S NR NR
CLUE 
,PUS nil 3 10 neg
 GNC 
pair.mobi NG NG Gono S S S S S S NG C.al,C.pa s r s neg neg
13 BHARATHI
35
898/11 S no NO S 1 yr 1 week NO NO NO NR NR TV nil 2 6 neg YEA,PSE,GNB E.coli R S R R S S NG NG TV C.al s s neg neg
14 KAVITHA
21
866/11 S no NO S
10 
days 1 mon NO NO NO NR NR nil nil 2 4 neg PUS CELL NG NG NG NG NG neg POS
15 BAVANI
35
950/11 S no S NO 3 mon 60 days NO NO S NR NR CLUE nil 2 3 neg nil
 A  
Strep S S S R S S NG NG NG NG neg neg
16 SUSILA 28 952/11 S no S NO 1 1 mon NO NO NO NR NR CLUE nil 3 8 neg nil NG GV S R S NG NG NG neg neg
17 ASHA 37 953/11 S no S NO 7 yr 1 week NO NO S NR NR CLUE nil 3 7 neg nil NG GV R R S NG NG NG posi neg
18 JOTHILAKSHMI
30
961/11 S no NO NO
30 
days no S NO NO NR NR nil YEAST,PS 1 1 neg YEA,PSEUDO NG NG NG NG C.gl r s s neg POS
19 SELVI
44
969/11 S no NO NO
60 
days no S NO NO not test not test nil nil 2 1 neg nil NG NG NG NG C.gl s s s neg POS
20 LILLI
40
976/11 S no NO S 4 yrs 8 mon NO NO NO not test not test PUS YEAST,PS 2 5 neg PUS CELLS
 B   
Strep S R S R S S NG NG NG C.pa s r s neg neg
21 VASANTHI
38
1013/11 S no NO NO 1.5 yr no S NO NO NR NR nil YEAST,PS 2 1 neg PUS,YEA,PSE NG NG NG NG C.al,C.gl s s s neg POS
nil
nil
nil nil
nil nil nil nil
nil nil
nil nil nil nil
nil nil nil
nil nil
nil nil nil nil
nil nil nil
nil nil nil
nil nil nil
nil nil nil
nil nil nil nil
nil nil
nil
nil nil nil nil
nil nil nil
nil nil
nil nil nil
nil nil nil
nil
nil nil
nil nil nil
22 POONGODI
36
1027/11 S no S NO
90 
days 60 days NO NO NO NR NR TV nil 2 4 pos nil NG NG NG TV NG neg POS
23 SELVI
38
1028/11 S no S NO
15 
days 15 days NO NO NO NR NR nil nil 2 2 neg nil E.coli R R S R S S NG NG NG NG neg neg
24 LAKSHMI
27
1029/11 S no S NO
45 
days 30 days NO NO NO NR NR PUS nil 3 1 neg YEA,PSEUDO NG NG NG NG NG neg neg
25 NABISHA
35
999/11 S no NO NO 3 days no NO NO S NR NR nil YEAST,PS 1 5 neg YEAST,DIP NG GV S S S NG NG C.tr,C.kr r r s neg neg
26 NISHA
40
1043/11 S no S NO
15 
days 21 days NO NO NO NR NR PUS nil 2 4 neg nil NG Peptost R S S NG NG C.al s s s neg neg
27 SHANTHI
37
1044/11 S no S NO
mc1-
13yr,
mc2-1 7 days NO NO NO NR NR CLUE nil 4 9 neg PUS CELLS NG GV S R S NG NG C.al s s s neg POS
28 SHANTHI
36
101/11 S no NO NO 1 day no S NO NO NR NR
CLUE,P
US nil 3 3 neg nil NG NG NG NG NG neg POS
29 NASEEMA
38
1052/11 S no NO S 1 day 7 days NO NO NO NR NR nil nil 1 4 neg nil NG NG NG NG C.al s s s neg POS
30 JAYANTHI
35
1056/11 S no S NO
30 
days 7 days NO NO NO NR NR CLUE nil 3 7 neg nil
  B 
strep S R R R S S NG NG NG NG neg neg
31 RAMZAN BEEVI
28
1065/11 S no S NO 2 days 5 days NO NO NO NR NR nil nil 2 5 neg PUS CELLS NG NG NG NG C.tr s s s neg POS
32 PRIYA 34 1076/11 S no S NO 4 yrs 15 days NO NO NO NR NR nil nil 2 1 neg YEAST NG NG NG NG NG neg neg
33 UMA
24
002O/11 S no NO S 5 days 15 days NO NO NO NR NR
CLUE,P
US nil 3 2 neg nil NG
Fusoba
c S S R NG NG NG neg POS
34 SELVI
32
1077/11 S no S NO
45 
days 60 days NO VVC NO NR NR
CLUE,P
US nil 2 0 neg nil NG Clostri R S S NG NG C.gl s s s neg neg
35 PARIMALA
30
1078/11 S no S NO 6 days 20 days NO NO NO NR NR nil YEAST,PS 2 4 neg YEA,PSEUDO NG NG NG NG C.al, C.kr r r s neg neg
36 LEELA
38
1122/11 S no NO S 1 day 7 days NO NO NO NR NR nil YEAST,PS 1 3 neg YEA,PSEUDO NG NG NG NG NG neg POS
37 JAYANTHI 32 1127/11 S no S NO 2 yrs 30 days NO NO NO NR NR CLUE nil 3 3 neg nil NG NG NG NG C.al s s s neg neg
38 UMARANI 40 1170/11 S no NO NO 7 days no NO NO S NR NR nil nil 2 4 neg nil NG NG NG NG C.gl s s s neg neg
39 JAYABARATHI 31 1191/11 S no NO NO 2 days no NO HSV S NR NR CLUE nil 3 6 neg nil NG NG NG NG NG neg neg
40 CHANDRA 35 1194/11 S no NO S 10 7 days NO NO NO NR NR PUS nil 2 5 neg nil NG Clostri R S S NG NG NG neg neg
41 MEENAKSHI
60
1212/11 S no NO NO 15 yrs no S NO NO NR NR nil YEAST 1 2 neg YEAST NG NG NG NG NG neg POS
42 USHA 30 1217/11 S no S NO 7 days 30 days NO NO NO NR NR nil nil 3 8 neg nil NG GV S R S NG NG C.gl s s s neg neg
43 JAYANTHI BAI 41 1220/11 S no NO NO 120 no S NO NO NR NR nil YEAST 2 0 neg YEAST NG NG NG NG C.pa s r s neg neg
44 RENUKA
30
1235/11 S no NO NO 7 days no NO
OLD 
HSV NO NR NR  PUS nil 2 0 neg PUS ,GNB E.coli R S R R S S NG NG NG NG neg neg
nil
nil
nil
nil
nil
nil nil
nil
nil nil nil
nil nil nil
nil nil nil
nil nil
nil nil
nil nil
nil nil nil
nil nil nil
nil nil nil
nil nil nil
nil nil nil
nil nil
nil nil nil
nil nil nil nil
nil nil nil
nil nil nil nil
nil nil nil
nil nil nil nil
nil nil
nil nil nil
nil nil nil
nil
45 LAKSHMI
35
1244/11 S no s NO
separa
ted 5 days NO NO NO NR NR
CLUE,P
US nil 4 8 neg PUS CELLS NG GV S S S NG TV NG neg neg
46 RUKMANI
40
1245/11 S no NO S 1 yr 5 days NO
MC,H
SV LIP S S,P ART NR PUS nil 2 1 neg nil NG NG NG NG NG neg POS
nil nil nil
nil nil nil nil
47 LAKSHMI
30
1303/11
S,hys
terec
tomy no NO NO
60 
days no NO NO NO NR NR nil nil 2 1 neg nil NG NG NG NG NG pos neg
48 KALA
27
1261/11 S no S NO 1 day 7 days NO BV NO NR NR nil nil 2 8 neg
PUS, GNC 
PAIR NG NG Gono IS R S S S S NG NG neg neg
49 NEELAVATHI
32
1304/11 S no NO S 7 days 2 yrs NO NO NO NR NR nil YEAST,PS 1 3 neg PUS CELLS NG NG NG NG C.al s s s neg neg
50 GEETHA
32
1322/11 S no S NO 3 days 10 days NO NO NO NR NR TV nil 1 1 pos DIP,GPC S.aure R S R R S S NG NG TV NG neg neg
51 KAVERI
50
1343/11 S no NO S 5 yrs 10 days NO NO NO NR NR nil YEAST,PS 2 0 neg PUS ,YEA NG NG NG NG C.al s s s neg POS
52 JAYANTHI
25
578/12 S no NO S 1mon 10 days NO NO NO NR NR nil YEAST 1 3 neg nil NG NG NG NG C.gl s s s neg POS
53 SUNDARI
38
605/12 S no NO S
mc1-
10 
day,m 60 days NO NO S,ART S,P ART NR nil YEAST 1 2 neg YEAST NG NG NG NG C.al s r s pos POS
54 PUSHPA
28
606/12 S no NO NO 5mon no NO NO S,ART S,P ART NR nil YEAST 1 2 neg YEAST NG NG NG NG C.gl s s s neg neg
55 AQUIB 22 671/12 S no NO NO 6mon no NO NO S NR NR CLUE nil 4 3 neg nil NG NG NG TV NG neg neg
56 BHARATHI
25
712/12 S no NO NO
15 
days no NO NO S NR NR nil YEAST,PS 0 4 neg YEAST,PSE NG NG NG NG C.al s s s neg neg
57 MALLIGA
52
717/12 S no NO NO 8 yrs no S NO NO NR NR nil nil 1 1 neg nil NG NG NG NG NG neg POS
58 MADHAVI 32 720/12 S no NO NO 5 days no NO NO S NR NR nil nil 3 4 neg nil NG NG NG NG NG pos neg
59 JANSIRANI
31
735/12 s no NO S 2 yrs 4 days NO NO NO NR NR TV nil 3 4 pos nil NG NG NG NG NG neg POS
60 DEVI
28
725/12 s no NO NO 5 mon no NO NO S,HIV NR NR
CLUE,P
US nil 4 7 neg PUS CELLS NG Peptost R S S NG NG NG neg POS
61 SUNDARI
45
743/12 S no NO NO WID no S NO NO NR NR nil YEAST,PS 0 1 neg YEAST NG NG NG NG C.gl s s s neg neg
62 KALA
30
744/12 S no NO S 1 mon 3 mon NO NO NO NR NR nil YEAST,PS 1 3 neg YEAST,PS NG NG NG NG C.tr s s s neg neg
63 SANGEETHA
29
862/12 S no NO NO 6 mon no NO NO S R NR nil nil 1 3 neg nil NG NG NG NG NG neg POS
64 MARY
33
391/12 S no NO NO 1 mon no NO NO NO NR NR nil nil 0 1 neg nil NG NG NG NG NG neg POS
65 MUNIYAMMAL
50
865/12 S no NO NO 5 yrs no NO VVC S,ART S,ART NR nil nil 1 4 neg nil S.aure R S R R S S NG NG NG NG neg neg
nil
nil
nil
nil
nil
nil
nil
nil
nil
nil
nil
nil
nil
nil nil nil nil
nil nil nil
nil nil nil
nil nil nil
nil
nil nil nil
nil nil nil
nil
nil
nil nil nil
nil nil nil
nil
nil nil
nil nil
nil nil nil
nil
nil nil
nil nil nil
nil nil nil
nil
nil nil
nil
nil
nil
1 VIMALA
58
471/11 NO S NO S 1 mon no NO NO NO NR NR nil YEAST,PS 1 5 neg YEAST,PSE NG  NG NG NG C.gl s s s neg neg
2 SUMITRA
23
433/11 NO S S NO
mc1-
2yr,mc
2-1 1wk NO NO NO S,ART NR CLUE nil 3 8 neg nil NG NG NG NG NG neg neg
3 SARASWATHY 25 715/11 NO S NO S 2 days 15 days NO NO NO NR NR nil nil 3 5 neg nil NG NG NG NG NG pos neg
4 SUDHA 28 442/11 NO S NO S 7 days 5 days NO NO NO NR NR CLUE nil 3 7 neg nil NG GV S R S NG NG NG neg neg
5 LAKSHMI
35
891/11 NO S NO NO 2 days no NO
OLD 
VVC NO NR NR nil YEAST,PS 1 3 neg YEA,PSEUDO NG NG NG NG C.gl s s s neg neg
6 SELVI
37
930/11 NO S NO NO 7 days no S WART NO NR NR nil YEAST,PS 2 3 neg YEA,PSEUDO NG NG NG NG NG neg POS
7 LAVANYA 30 962/11 NO S NO NO 6 mon no NO NO S NR s,1:4 nil nil 2 3 neg nil NG NG NG NG NG neg neg
8 INDIRA
36
1022/11 NO S S NO
30 
days 3 week NO NO NO NR NR PUS nil 3 2 neg nil NG NG NG NG NG neg POS
9 ANGABANU
35
1024/11 NO S S NO
15 
days 10 days S NO NO NR NR nil YEAST,PS 1 2 neg YEA,PSEUDO NG NG NG NG C.al s s s neg POS
10 RAJI 35 1025/11 NO S S NO 1 day 7  days NO NO NO NR NR PUS nil 2 5 neg nil NG NG NG NG NG neg neg
11 ZAMMEM 37 1121/11 NO S NO S 3 days 10 days NO NO NO NR NR nil YEAST 2 5 neg YEAST NG NG NG NG NG neg neg
12 LAKSHMI 32 1126/11 NO S S NO 7 days 60 days NO NO NO NR NR nil nil 2 0 neg YEAST NG NG NG NG C.tr s s s neg neg
13 INDUMATHI 27 288/11 NO S NO S 2 days 10 days NO OLD NO NR NR CLUE nil 3 5 neg YEAST NG NG NG NG C.gl s s s neg neg
14 MEERA
35
1269/11 NO S NO NO
15 
days no NO NO NO not test not test nil nil 1 1 neg YEAST NG NG NG NG NG neg POS
15 SEETHA
28
1344/11 NO S NO S
60 
days
150  
days NO NO NO NR NR  PUS nil 2 5 neg PUS CELLS NG
Bacter
o S S R NG NG NG neg POS
16 RAZYABANU
27
668/12 NO S NO NO 4 days no NO NO S NR NR
CLUE,P
US nil 4 5 neg PUS CELLS Ente R S R R S S NG NG NG NG neg POS
17 LAKSHMI
38
718/12 NO S NO NO 2 days no NO NO S NR NR nil nil 3 4 neg PUS CELLS NG NG NG NG NG neg POS
18 RUBINI 23 677/12 NO S NO S 4 days 2 days NO NO NO NR NR nil nil 0 3 neg nil NG NG NG NG NG neg neg
19 RAMYA
28
735/12 NO S NO NO 5 mon no NO NO S,HIV NR NR
CLUE,P
US nil 4 7 neg PUS CELLS NG Peptost R S S NG NG NG neg POS
20 JOTHIMANI
35
755/12 NO s NO S
separa
ted,11 1 mon NO NO NO NR NR nil YEAST,PS 2 2 neg YEA,PSEUDO NG NG NG NG C.tr s s s neg neg
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S.no Name Age STD no Sub dis Obj dis FSW Mul Con Last MC Last  EMC Dia&ste Past VD Partn  HR HIV RPR Wet KOH Ams Nug Giem  GS-v,c smear Aer Ba P/A Ci E/G Co Ak Ce An.Ba P M V Gono P Ci T Az S Ce  TV Fungal F I Am Tzan  Chla
1 PREMA 34 413/11 S no NO NO 1 mon no NO NO NO NR NR nil YEAST 2 4 neg YEAST NG NG NG NG C.al s s s neg neg
2 MARGARET 32 425/11 S no NO NO 7 days no NO NO NO NR NR CLUE nil 4 6 neg GPC  NG peptost R S S NG NG NG neg neg
3 SIVAKUMARI 29 522/11 S no NO NO 30 days no NO NO NO NR NR CLUE nil 2 4 neg GPC CHAINS NG NG NG NG C.pa,C.al s r s neg neg
4 JAYAMARY 22 526/11 S no NO NO 10 days no NO NO NO NR NR nil nil 3 4 neg DIPTHE NG NG NG NG NG neg neg
5 INDIRA 29 529/11 S no NO NO 10 days no NO NO NO not test not test TV nil 2 5 neg nil NG NG NG TV NG neg POS
6 MALLIKA 23 541/11 S no NO NO 3 days no NO NO NO NR NR nil YEAST,PS 0 2 neg YEA,PSEUDO NG NG NG NG C.pa s s s neg neg
7 KALA 21 550/11 S no NO NO 7 days no NO NO NO NR NR CLUE nil 3 4 neg PUS CELLSl NG NG NG NG NG neg neg
8 NAGALAKSHMI 40 549/11 S no NO NO 60 days no NO NO NO NR NR CLUE nil 3 6 neg PUS CELLS NG NG NG NG C.gl s s s neg POS
9 RAJALAKSHMI 30 560/11 S no NO NO 1 day no NO NO NO NR NR CLUE nil 3 7 neg GPC CHAINS NG GV NG NG NG neg neg
10 LAKSHMI 45 697/11 S no NO NO 30 days no NO NO NO NR NR nil YEAST,PS 0 2 neg YEA,PSE,GPC B str R S R R S S NG NG NG NG neg neg
11 REVATHY 25 771/11 S no NO NO 7 days no NO NO NO NR NR TV nil 3 3 pos nil NG NG NG TV NG neg neg
12 MALAR 30 792/11 S no NO NO 7 days no NO NO NO NR NR CLUE,PUS nil 2 3 neg nil NG GV NG NG NG neg neg
13 SHANKARI 22 800/11 S no NO NO 3 days no NO NO NO NR NR CLUE YEAST,PS 4 8 neg YEA,PUS CELL NG NG NG NG NG neg POS
14 NABISHA 35 814/11 S no NO NO 1 day no NO NO NO NR NR CLUE,PUS nil 2 6 neg PUS CELL,YEA NG NG NG NG NG neg POS
15 MANJULA 32 902/11 S no NO NO 6 mon no NO NO NO NR NR nil nil 3 5 neg nil NG NG NG NG NG neg neg
16 VARALAKSHMI 37 924/11 S no NO NO 90 days no NO NO NO NR NR CLUE nil 3 6 neg GPC CHAINS B str S R S R S S NG NG NG NG neg neg
17 SUMATHI 26 971/11 S no NO NO 4 days no NO NO NO not test not test nil nil 2 5 neg nil NG NG NG NG C.pa r s s neg neg
18 BAKYALAKSHMI 39 973/11 S no NO NO 6 days no NO NO NO NR NR nil YEAST,PS 2 9 neg YEA,PSEUDO NG GV NG NG C.kr r s s neg POS
19 BANUMATHI 48 981/11 S no NO NO 60 days no NO NO NO NR NR PUS nil 2 5 neg PUS CELL NG clostri R S S NG NG NG neg POS
20 USHARANI 46 983/11 S no NO NO 5 days no NO NO NO NR NR PUS nil 3 7 neg nil NG peptost R S S NG NG NG neg neg
21 SASIKALA 28 1041/11 S no NO NO 7 days no NO NO NO NR NR nil nil 2 3 neg YEA,PSEUDO NG NG NG NG NG neg POS
22 MALLIGA 35 1057/11 S no NO NO 2 days no NO NO NO NR NR CLUE nil 4 9 neg MOBI,YEA NG GV,Mob S R S NG NG C.al s s s neg POS
23 SITHI FATHIMA 32 1068/11 S no NO NO 3 days no NO NO NO NR NR few PUS nil 2 1 neg nil NG NG NG NG NG neg neg
24 ANITHA 28 1139/11 S no NO NO 7 days no NO NO NO NR NR CLUE nil 2 1 neg nil NG NG NG NG C.al s s s neg neg
25 MALA 29 748/11 S no NO NO 7 days no NO NO NO NR NR nil YEAST,PS 1 1 neg YEA,PSEUDO NG NG NG NG C.gl ,C.al s s s neg neg
26 LAKSHMI 30 1190/11 S no NO NO 30 days no NO NO NO NR NR nil YEAST,PS 2 5 neg YEA,PSEUDO NG NG NG NG NG neg neg
27 EPSEEBA 36 1195/11 S no NO NO 2 days no NO NO NO NR NR CLUE,PUS nil 3 5 neg YEAST NG peptost R S S NG NG C.al s s s neg POS
28 MEENA 33 1238/11 S no NO NO 1 day no NO NO NO NR NR few PUS nil 2 6 neg nil NG NG NG NG NG neg neg
29 DEVI 32 1259/11 S no NO NO 15 days no NO NO NO NR NR nil nil 2 0 neg YEAST,GPC NG NG NG NG NG neg POS
30 THULASI 21 1263/11 S no NO NO 1 yr no NO NO NO NR NR CLUE nil 4 7 neg MOBI,YEA NG NG NG NG NG neg neg
31 RAMZAN 34 1277/11 S no NO NO 4 days no NO NO NO NR NR nil YEAST 1 4 neg YEA,PUS CELL NG NG NG NG C.gl s s s neg neg
32 VELANKANNI 42 694/12 S no NO NO 9mon no NO NO NO NR NR nil nil 2 1 neg nil NG NG NG NG NG neg neg
33 PUSPHA 38 724/12 S no NO NO 6 mon no NO NO NO NR NR nil YEAST 0 3 neg YEAST NG NG NG NG NG neg neg
34 FATHIMA 36 851/12 S no NO NO 15 days no NO NO NO NR NR nil nil 3 1 neg nil NG NG NG NG NG neg neg
35 VEERAMMA 35 861/12 S no NO NO 6 mon no NO NO NO NR NR nil nil 0 4 neg nil NG NG NG NG NG neg neg
1 BAKIAM 28 709/11 NO S NO NO 6 days no NO NO NO NR NR nil nil 3 1 neg nil NG NG NG NG NG neg neg
2 KAMATCHI 20 790/11 NO S NO NO 3 days no NO NO NO NR NR nil YEAST,PS 2 4 neg YEA,PSEUDO NG NG NG NG C.pa r r s neg neg
3 VANITHA 29 1066/11 NO S NO NO 8  mon no NO NO NO NR NR nil nil 2 1 neg PUS CELLS NG NG NG NG NG neg POS
4 DHANAM 38 689/12 NO S NO NO 3 mon no NO NO NO NR NR CLUE nil 4 9 neg YEAST NG NG NG NG NG neg neg
5 MAHALAKSHMI 25 698/12 NO S NO NO 3 mon no NO NO NO NR NR few PUS nil 2 1 neg nil NG NG NG NG NG neg neg
6 MAHALAKSHMI 27 727/12 NO S NO NO 1 day no NO NO NO NR NR CLUE nil 2 1 neg nil NG NG NG NG NG neg neg
7 SUNDARI 30 728/12 NO s NO NO 4 days no NO NO NO NR NR nil YEAST,PS 1 1 neg YEA,PSEUDO NG NG NG NG C.gl s s s neg neg
8 MUTHULAKSHMI 24 850/12 NO S NO NO 2 mon no NO NO NO NR NR nil YEAST,PS 2 5 neg YEA,PSEUDO NG NG NG NG C.al s s s neg neg
9 DEVI 27 852/12 NO S NO NO 1 week no NO NO NO NR NR CLUE,PUS nil 3 5 neg PUS CELLS NG NG NG NG NG neg neg
10 BASARIYA 32 864/12 NO S NO NO 3 days no NO NO NO NR NR few PUS nil 2 6 neg nil NG NG NG NG NG neg neg
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